<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Physiol Anthropol</journal-id><journal-id journal-id-type="iso-abbrev">J Physiol Anthropol</journal-id><journal-title-group><journal-title>Journal of Physiological Anthropology</journal-title></journal-title-group><issn pub-type="ppub">1880-6791</issn><issn pub-type="epub">1880-6805</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7517057</article-id><article-id pub-id-type="publisher-id">239</article-id><article-id pub-id-type="doi">10.1186/s40101-020-00239-5</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Implications of human activities for (re)emerging infectious diseases, including COVID-19</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Sabin</surname><given-names>Nundu Sabiti</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Calliope</surname><given-names>Akintije Simba</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Simpson</surname><given-names>Shirley Victoria</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Arima</surname><given-names>Hiroaki</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Ito</surname><given-names>Hiromu</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Nishimura</surname><given-names>Takayuki</given-names></name><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Yamamoto</surname><given-names>Taro</given-names></name><address><email>taro.daichi.yamamoto@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.174567.6</institution-id><institution-id institution-id-type="ISNI">0000 0000 8902 2273</institution-id><institution>Department of International Health and Medical Anthropology, Institute of Tropical Medicine, </institution><institution>Nagasaki University, </institution></institution-wrap>1-12-4 Sakamoto, Nagasaki, 852-8523 Japan </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.174567.6</institution-id><institution-id institution-id-type="ISNI">0000 0000 8902 2273</institution-id><institution>Graduate School of Biomedical Sciences, </institution><institution>Nagasaki University, </institution></institution-wrap>Nagasaki, Japan </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.174567.6</institution-id><institution-id institution-id-type="ISNI">0000 0000 8902 2273</institution-id><institution>Leading Program, Graduate School of Biomedical Sciences, </institution><institution>Nagasaki University, </institution></institution-wrap>Nagasaki, Japan </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.177174.3</institution-id><institution-id institution-id-type="ISNI">0000 0001 2242 4849</institution-id><institution>Department of Human Science, Faculty of Design, </institution><institution>Kyushu University, </institution></institution-wrap>Fukuoka, Japan </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.174567.6</institution-id><institution-id institution-id-type="ISNI">0000 0000 8902 2273</institution-id><institution>Department of Public Health, Graduate School of Biomedical Sciences, </institution><institution>Nagasaki University, </institution></institution-wrap>Nagasaki, Japan </aff></contrib-group><pub-date pub-type="epub"><day>25</day><month>9</month><year>2020</year></pub-date><pub-date pub-type="pmc-release"><day>25</day><month>9</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>39</volume><elocation-id>29</elocation-id><history><date date-type="received"><day>21</day><month>5</month><year>2020</year></date><date date-type="accepted"><day>16</day><month>9</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2020</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">Since 1980, the world has been threatened by different waves of emerging disease epidemics. In the twenty-first century, these diseases have become an increasing global concern because of their health and economic impacts in both developed and resource-constrained countries. It is difficult to stop the occurrence of new pathogens in the future due to the interconnection among humans, animals, and the environment. However, it is possible to face a new disease or to reduce the risk of its spread by implementing better early warning systems and effective disease control and prevention, e.g., effective global surveillance, development of technology for better diagnostics, effective treatments, and vaccines, the global political will to respond to any threats and multidisciplinary collaboration involving all sectors in charge of good health maintenance. In this review, we generally describe some factors related to human activities and show how they can play a role in the transmission and spread of infectious diseases by using some diseases as examples. Additionally, we describe and discuss major factors that are facilitating the spread of the new pandemic known as COVID-19 worldwide.</p></abstract><kwd-group xml:lang="en"><title>Key words</title><kwd>Humans</kwd><kwd>Factors</kwd><kwd>(Re)emerging infectious disease</kwd><kwd>Coronavirus</kwd></kwd-group><funding-group><award-group><funding-source><institution>Japan Society for the Promotion of Science</institution></funding-source><award-id>JP19H05737</award-id><principal-award-recipient><name><surname>Yamamoto</surname><given-names>Taro</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>JP19K24679</award-id><principal-award-recipient><name><surname>Yamamoto</surname><given-names>Taro</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2020</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par25">Emerging infectious diseases (EIDs) are diseases recently identified or previously unknown infections that cause public health threats, either locally or internationally [<xref ref-type="bibr" rid="CR1">1</xref>]. In contrast, reemerging infectious diseases are known diseases that reappear and increase in incidence but that in the past may have fallen to levels so low that they were no longer considered a public health problem [<xref ref-type="bibr" rid="CR1">1</xref>]. In the twenty-first century, these diseases have increasingly become a global concern [<xref ref-type="bibr" rid="CR2">2</xref>] due to their health and economic impacts in both developed and resource-constrained countries. It has been estimated that out of approximately 400 known emerging pathogens, 25% occur as human pathogens [<xref ref-type="bibr" rid="CR3">3</xref>]. In other reports, approximately 175 species are associated with emerging diseases, of which approximately 75% are of zoonotic origin [<xref ref-type="bibr" rid="CR4">4</xref>]. Most of these zoonoses have occurred due to increased contact between humans and animals [<xref ref-type="bibr" rid="CR5">5</xref>&#x02013;<xref ref-type="bibr" rid="CR8">8</xref>]. These zoonoses account for approximately 44%, 30%, 11%, 9%, and 6% of viruses or prions, bacteria or rickettsia, protozoa, fungi, and helminths, respectively [<xref ref-type="bibr" rid="CR9">9</xref>]. In the post-1980 period, some zoonotic pathogens were responsible for outbreaks such as <italic>Escherichia coli</italic> O157 in the 1980s [<xref ref-type="bibr" rid="CR10">10</xref>], the avian strain of influenza in Hong-Kong in 1997 [<xref ref-type="bibr" rid="CR11">11</xref>], West Nile virus in 1999 [<xref ref-type="bibr" rid="CR12">12</xref>], the outbreak of chikungunya fever in Italy in 2007 [<xref ref-type="bibr" rid="CR13">13</xref>], the epidemic of Q fever in the Netherlands [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>], the outbreak of severe acute respiratory syndrome (SARS) in 2002 caused by very virulent strains of new coronaviruses [<xref ref-type="bibr" rid="CR16">16</xref>&#x02013;<xref ref-type="bibr" rid="CR18">18</xref>], Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012 [<xref ref-type="bibr" rid="CR19">19</xref>], and avian influenza, such as A/H1N1 in 1997 in Hong-Kong [<xref ref-type="bibr" rid="CR20">20</xref>], A/H7N7 in 2004 in the US [<xref ref-type="bibr" rid="CR21">21</xref>], A/H7N2 in 2007 in the UK [<xref ref-type="bibr" rid="CR22">22</xref>], and A/H7N9 in China [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. Recently, major outbreaks of Ebola virus disease (EVD) threatened populations in West African countries between 2013 and 2016, with 28,603 cases and 11,310 deaths [<xref ref-type="bibr" rid="CR24">24</xref>], and in the Democratic Republic of Congo (DRC) from 2018 to 2020, with 3444 cases and 2264 deaths [<xref ref-type="bibr" rid="CR25">25</xref>]. Currently, the entire world is facing an unprecedented pandemic caused by a new strain of coronavirus called coronavirus disease 2019 (COVID-19) [<xref ref-type="bibr" rid="CR26">26</xref>].</p><p id="Par26">Wolfe et al. [<xref ref-type="bibr" rid="CR27">27</xref>] identified five stages leading to endemic human disease, where a pathogen restricted to infecting animals may be transformed into a human pathogen. The first stage is when a pathogen is present in animals but has not yet been detected in humans under natural conditions; the second is when a pathogen has been transmitted from animals to humans, but there is no evidence of human-human transmission (e.g., tetanus, rabies); the third is when a pathogen can undergo only a few cycles of secondary transmission between humans and shortly die out, where a subsequent wave will require the involvement of animal hosts (e.g., Ebola virus, Marburg virus, monkeypox virus); the fourth is when a pathogen undergoes long sequences of secondary transmission between humans without the involvement of animal hosts (many vector-borne diseases, e.g., dengue virus, yellow fever virus, cholera, influenza A, typhus); and the fifth is when a pathogen previously restricted to animals later evolves into an exclusively human pathogen (e.g., smallpox, measles, syphilis, falciparum malaria, rubella, mumps, hepatitis B, tuberculosis, AIDS) [<xref ref-type="bibr" rid="CR27">27</xref>]. Consequently, the passage from one stage to another depends on the host-pathogen-environment interconnection [<xref ref-type="bibr" rid="CR28">28</xref>]. The emergence of infection is influenced by the interconnecting domains of determinants such as physical and environmental factors; ecological factors; genetic and biological factors; and social, political, and economic factors [<xref ref-type="bibr" rid="CR29">29</xref>]. Therefore, these determinants may influence the emergence and spread of infectious diseases. According to Chareonsook et al. [<xref ref-type="bibr" rid="CR30">30</xref>], human demographic changes and behavior, travel and commerce, ecological changes, technology and industry, microbial adaptation and change, and the breakdown of public health measures are sufficient factors for the emergence and spread of infectious diseases. Subsequently, Lederberg et al. [<xref ref-type="bibr" rid="CR29">29</xref>] identified additional factors such as human vulnerability, economic development, land use, lack of political will, poverty and social inequality, war and famine, and intent to harm.</p><p id="Par27">In the twenty-first century, many outbreaks have occurred around the world, such as EVD, avian influenza, and coronaviruses (SARS, MERS, COVID-19), because of factors related to human activities. Here, we will describe some human-related factors and give some examples.</p></sec><sec id="Sec2"><title>Human-related factors influencing the transmission and spread of infectious diseases</title><sec id="Sec3"><title>Globalization (international travel and trade)</title><p id="Par28">The twenty-first century has ushered in an era where infectious diseases are occurring at an unprecedented frequency and speed. A coordinated global response is needed; however, in this globalized environment of interdependent trade, travel, and migrations, pathogens have no geopolitical borders [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR31">31</xref>].</p><p id="Par29">Recently, EIDs such as COVID-19, EVD, Lassa fever, and SARS have been an issue of global concern. With globalization, the risk of the emergence of new diseases is increasing since humans have more chances to be exposed to new pathogens. Additionally, the risk of international spread of infectious diseases is increasing because of increased international travel. The process of globalization potentially influences a broad range of biological, environmental, and social factors that affect the burden of many critical human infections [<xref ref-type="bibr" rid="CR32">32</xref>]. Various international organizations and governments have been trying to establish better global systems to respond to EIDs. However, the SARS outbreak in 2003, the EVD outbreak in West Africa in 2014, and the current COVID-19 pandemic have highlighted that the current global system is still not fully ready for such (re)emerging infectious diseases [<xref ref-type="bibr" rid="CR33">33</xref>]. These EIDs threaten public health, as well as the global economy, and are sustained by increasing global trade and travel. However, the disruption of the human-ecological system is another potential factor. Travelers could play a role in importing EIDs and could be a carrier of major epidemics [<xref ref-type="bibr" rid="CR34">34</xref>]. It has been observed that (re)emerging infectious diseases are imported by travelers or tourists in Europe, such as chikungunya and dengue in France and Italy as well as COVID-19 in France from China [<xref ref-type="bibr" rid="CR35">35</xref>&#x02013;<xref ref-type="bibr" rid="CR37">37</xref>]. Cross-border movements of people, as well as trade in goods and services, are increasing the challenges for infectious disease control. As an example, in 2005, evidence of outbreak importation through international travel was found with the isolation of H5N1 type A influenza virus from two mountain hawk eagles that were illegally imported from Thailand in an airline cabin carry-on baggage to Belgium [<xref ref-type="bibr" rid="CR38">38</xref>]. The risk of infectious diseases rises with the increased mobility of people, growth in the international trade in food and biological products, and social and environmental changes. It is evident that trade and international travel are essential to humankind. However, some preventive measures, such as travel restrictions and creation of awareness among trade and travel stakeholders, are paramount to flatten the curve. In recent years, trade embargoes or travel restrictions have been replaced with sensitive early warning surveillance, rapid verification procedures, and international response networks as well as epidemic preparedness through stockpiles of essential medicines [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]. However, studies have proven that if implemented within 2 weeks of cases, travel restrictions are 99% effective in conjunction with border restrictions that prevent the entry of infected travelers. Additionally, a 90% restriction on long-distance flights can lead to delays in the epidemic peak that range from a few days to a few weeks [<xref ref-type="bibr" rid="CR41">41</xref>&#x02013;<xref ref-type="bibr" rid="CR44">44</xref>]. These developments affect all elements of the infectious disease chain: hosts, agents, and vectors [<xref ref-type="bibr" rid="CR45">45</xref>]. Moreover, we must not ignore the fact that outbreaks are themselves associated with significant costs in terms of lost trade and tourism revenue. Therefore, a fear of economic penalties and social stigma can arise and can sometimes lead authorities to underreport data in epidemics, hence risking serious public health consequences.</p></sec><sec id="Sec4"><title>Changes in environment/ecological changes</title><p id="Par30">Global environmental changes are due to human modifications to the environment [<xref ref-type="bibr" rid="CR46">46</xref>]. National, regional, and global environmental threats to human health according to the World Health Organization (WHO) include &#x0201c;climate change, stratospheric ozone depletion, changes in ecosystems due to loss of biodiversity, changes in hydrological systems and the supplies of fresh water, land degradation, urbanization, and stresses on food-producing systems&#x0201d; [<xref ref-type="bibr" rid="CR47">47</xref>].</p><p id="Par31">Changes in the environment, including food-handling practices, agriculture, and changes in water ecosystems, seem to increase the chance of contact with a reservoir host encountering microorganisms previously unknown to humans. Anthropogenic changes alter the environment by increasing the risk of transmission of pathogens unfamiliar to humans [<xref ref-type="bibr" rid="CR48">48</xref>].</p><p id="Par32">It has been established that there is a relationship between infectious disease outbreaks and changes in the environment, including climate change events [<xref ref-type="bibr" rid="CR49">49</xref>]. Ecological changes are one of the most important drivers of (re)emerging infectious diseases, specifically agricultural development, climate changes, food-handling practices, changes in water ecosystems, deforestation, and reforestation [<xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR51">51</xref>].</p><p id="Par33">Climate change results in differences in weather conditions and patterns of extreme weather events. Spatiotemporal changes in climate affect the reproduction, development, survival, and livability of pathogens, hosts, and their interaction with human beings. Dramatic and unforeseen changes in weather conditions have profound effects on many infectious diseases. Extreme weather events and meteorological hazards make it more complicated to predict the implications for disease pathogens, hosts, and transmission [<xref ref-type="bibr" rid="CR52">52</xref>&#x02013;<xref ref-type="bibr" rid="CR54">54</xref>]. The United Nations High Commissioner of Refugees (UNHCR) estimates that an average of 22.5 million people have been displaced by weather-related events or climate since 2008 [<xref ref-type="bibr" rid="CR55">55</xref>]. The literature on climate variations and infectious diseases demonstrates that climate-sensitive diseases, i.e., vector-borne and food/water-borne diseases, are vastly affected by climate variability and climate change [<xref ref-type="bibr" rid="CR56">56</xref>, <xref ref-type="bibr" rid="CR57">57</xref>]. Vector-borne diseases (VBDs) are the most climate sensitive. They have several climate drivers [<xref ref-type="bibr" rid="CR58">58</xref>], causing over 700,000 deaths annually, accounting for more than 17% of all infectious diseases and having the highest burden in tropical and subtropical areas, particularly affecting the most deprived populations [<xref ref-type="bibr" rid="CR59">59</xref>]. Some examples of VBDs of significance to humans and animals are malaria, schistosomiasis, dengue, chikungunya, and Lyme disease [<xref ref-type="bibr" rid="CR60">60</xref>&#x02013;<xref ref-type="bibr" rid="CR62">62</xref>]. Improving infrastructure and disease surveillance systems worldwide and funding health observatories would help to better detect and attribute the effects of climate change on VBD (re)emergence [<xref ref-type="bibr" rid="CR60">60</xref>&#x02013;<xref ref-type="bibr" rid="CR62">62</xref>]. The burden of food- and water-borne diseases (FWBDs) is found in some parts of developing countries and areas where food and water hygiene are inadequate. For example, in Africa, FWBDs account for 91 million illnesses, resulting in 137,000 deaths, annually [<xref ref-type="bibr" rid="CR63">63</xref>]. Important causes of food-borne diseases are noroviruses, <italic>Campylobacter</italic> spp., and nontyphoidal <italic>Salmonella</italic>, while those of water-borne diseases remain diarrheal diseases, such as cholera, <italic>Shigella</italic>, and poliomyelitis. Additionally, food-handling practices have been associated with SARS and H5N1 outbreaks [<xref ref-type="bibr" rid="CR48">48</xref>]. Proper water, sanitation, and hygiene interventions can significantly reduce FWBDs [<xref ref-type="bibr" rid="CR63">63</xref>].</p><p id="Par34">Agricultural development is a factor and the most typical way humans alter and interpose themselves into the environment [<xref ref-type="bibr" rid="CR64">64</xref>, <xref ref-type="bibr" rid="CR65">65</xref>]. It is the world&#x02019;s single most significant driver of global environmental change and is key to attaining Sustainable Development Goal (SDG) 2, which aims to end hunger, achieve food security and improved nutrition, and promote sustainable agriculture [<xref ref-type="bibr" rid="CR66">66</xref>, <xref ref-type="bibr" rid="CR67">67</xref>]. The expansion and intensification of agriculture come with massive habitat conversion, increasing use of agricultural inputs such as antibiotic growth promoters and pesticides, and contamination with animal waste [<xref ref-type="bibr" rid="CR68">68</xref>]. Several studies have linked agricultural land use or land use change with infectious disease risks. Significant associations were identified for malaria, spotted fever group rickettsioses, hookworm, scrub typhus, <italic>Schistosoma japonicum</italic>, and <italic>Trichuris trichiura</italic>.</p><p id="Par35">On the other hand, agricultural practices were implicated in the pandemic influenza outbreak, Nipah, and West Nile transmission [<xref ref-type="bibr" rid="CR48">48</xref>]. Exposure to livestock could result in 2&#x02013;4 times the risk of infection with vector-borne, bacterial, or zoonotic diseases [<xref ref-type="bibr" rid="CR69">69</xref>]. To withstand the future viability of agriculture, sustainable practices are required to meet rising human needs while contributing to the resilience and sustainability of landscapes, biospheres, and the Earth system [<xref ref-type="bibr" rid="CR67">67</xref>]. It has also been shown that deforestation and reforestation can influence the emergence of some pathogens. For example, reforestation has been linked to Lyme disease outbreaks [<xref ref-type="bibr" rid="CR56">56</xref>, <xref ref-type="bibr" rid="CR70">70</xref>].</p></sec><sec id="Sec5"><title>Human-wild animal interface</title><p id="Par36">Approximately three-fourths of human EIDs are caused by zoonotic pathogens [<xref ref-type="bibr" rid="CR71">71</xref>]. However, according to the WHO, humans coexist with animals in a variety of ways, either by hunting [<xref ref-type="bibr" rid="CR72">72</xref>] or by living as domestic animals [<xref ref-type="bibr" rid="CR73">73</xref>]. The interface among humans, animals, and the environment we share can be a source of diseases impacting public health [<xref ref-type="bibr" rid="CR74">74</xref>]. However, in most cases, reported causes for and drivers of the apparent trends in disease emergence are lacking in intense evidence-based research. However, there is circumstantial evidence to suggest that novel epidemics and disease syndromes are the results of changing agroecology and human behavior and movements, intensifying interfaces with certain wildlife species and climate change [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR75">75</xref>]. Although no clear evidence has been presented to date, hunting has been associated with zoonotic diseases [<xref ref-type="bibr" rid="CR72">72</xref>]. With modern ways of life, however, this hypothesis became obsolete with the low spillover from wild animals to humans. The possible reason was that when people lived as hunter-gatherers, they were always on the move, and it became difficult for microbes to keep up with their human hosts. Once people started living as farmers, they began residing in more significant numbers in the same place and were in daily contact with their accumulating feces for extended periods [<xref ref-type="bibr" rid="CR76">76</xref>]. Other evidence has shown that bushmeat is an essential source of protein and income in Africa despite its link with numerous EIDs, such as Ebola and Marburg [<xref ref-type="bibr" rid="CR7">7</xref>]. The increased demand and commercialization of these types of meat have exposed people to pathogens and thus facilitated the geographic spread of the diseases [<xref ref-type="bibr" rid="CR77">77</xref>]. All the aspects highlighted above have created conditions highly amenable for the spillover of microbes into the human ecosystem.</p><p id="Par37">Moreover, the domestication of wild animals has narrowed the gap between wild animals and humans. Evidence has shown that domesticated animals that were long ago associated with humans are the ones at the center of those that favor parasite/pathogen transmission not only to humans but also to all other domesticated animals [<xref ref-type="bibr" rid="CR78">78</xref>]. It has been revealed not only that humans are victims of the domestication of wild animals but also that the reverse is true. An example is that the occurrence of <italic>Taenia</italic> tapeworms in humans predated the development of agriculture, animal husbandry, and domestication of cattle or swine, and later, it accompanied early human dispersion out of Africa. Swine and cattle are thought to have acquired infections with <italic>Taenia</italic> species during their early domestication [<xref ref-type="bibr" rid="CR79">79</xref>]. Thus far, it is not possible to stop human-animal interconnections. However, it is possible to reduce the negative impact of the human-wild animal interface, which contributes to the emergence of infectious diseases, by responding before the occurrence of spillover events, epidemics or even pandemics [<xref ref-type="bibr" rid="CR80">80</xref>]. For example, people should be educated to stop harvesting bushmeat, especially by avoiding nonhuman primates; future zoonotic spillover events should be prevented through culturally appropriate education, and disease spread should be avoided through better disease surveillance [<xref ref-type="bibr" rid="CR81">81</xref>, <xref ref-type="bibr" rid="CR82">82</xref>].</p></sec><sec id="Sec6"><title>Antimicrobial resistance</title><p id="Par38">The resistance of microbes (viruses, bacteria, parasites, and fungi) to antimicrobials has contributed to the re-emergence of many diseases that were no longer considered a public health problem [<xref ref-type="bibr" rid="CR83">83</xref>], narrowing the range of antimicrobial drugs and representing a global public health concern [<xref ref-type="bibr" rid="CR84">84</xref>&#x02013;<xref ref-type="bibr" rid="CR86">86</xref>]. It has been estimated that approximately 700,000 annual deaths worldwide are a result of antimicrobial resistance (AMR) [<xref ref-type="bibr" rid="CR87">87</xref>], which poses a problem to achieve the United Nations SDGs [<xref ref-type="bibr" rid="CR88">88</xref>] and might reduce the gross domestic product by approximately 3.8% by 2050 [<xref ref-type="bibr" rid="CR89">89</xref>].</p><p id="Par39">It has been shown that AMR is the consequence of microbial adaptation and genetic changes that allow them to bypass the human immune system, infect human cells, and spread disease. These microbes can emerge and spread rapidly and become resistant to multiple antimicrobials at the same time [<xref ref-type="bibr" rid="CR90">90</xref>&#x02013;<xref ref-type="bibr" rid="CR94">94</xref>] by developing mechanisms to exchange or incorporate new genetic material into their genomes, exchanging virtually any stretch of DNA or RNA [<xref ref-type="bibr" rid="CR95">95</xref>]. Sometimes, even doctors prescribe inappropriate antimicrobials (i.e., an antimicrobial is not needed at all, or they prescribe the wrong drug or wrong dose) [<xref ref-type="bibr" rid="CR96">96</xref>], or physicians prescribe drugs with the wrong prescription doses or antibiotics with an incorrect duration of treatment [<xref ref-type="bibr" rid="CR97">97</xref>]. This practice contributes to the growth and spread of microbial resistance [<xref ref-type="bibr" rid="CR98">98</xref>] and can be responsible for nosocomial infections in hospitals. For instance, more than 90% of <italic>Staphylococcus aureus</italic> species were resistant to penicillin and beta-lactam antibiotics in hospitals in the United States (US) and were responsible for approximately 19,000 deaths in 1992 [<xref ref-type="bibr" rid="CR83">83</xref>]. Additionally, between 1989 and 1993, the incidence of vancomycin-resistant enterococci increased 20-fold in the US, and in 1997, the susceptibility of <italic>Staphylococcus aureus</italic> to vancomycin decreased in both the US and Japan [<xref ref-type="bibr" rid="CR99">99</xref>]. In the European Union (EU), approximately 15&#x02013;50% of <italic>Klebsiella pneumoniae</italic> species are resistant to carbapenems [<xref ref-type="bibr" rid="CR100">100</xref>]. Previously, methicillin-resistant <italic>Staphylococcus aureus</italic> (MRSA) was associated with severe invasive disease only in hospitals; however, in the last 20 years, it has been identified in the community and named community-associated (CA)-MRSA [<xref ref-type="bibr" rid="CR101">101</xref>]. As an example, CA-MRSA pneumonia is responsible for approximately 75&#x02013;85% of admitted patients and 20 to 60% of deaths in the intensive care unit [<xref ref-type="bibr" rid="CR102">102</xref>]. Currently, extended-spectrum &#x003b2;-lactamase resistance is endemic in hospitals and the community worldwide [<xref ref-type="bibr" rid="CR103">103</xref>, <xref ref-type="bibr" rid="CR104">104</xref>].</p><p id="Par40">Moreover, multidrug-resistant (MDR)-<italic>Acinetobacter baumannii</italic> isolates carrying Cefotaxime-M (CTX-M) enzymes are now responsible for nosocomial infections and among specific populations and accountable for high mortality and morbidity [<xref ref-type="bibr" rid="CR105">105</xref>], as well as cholera O1 and O139 [<xref ref-type="bibr" rid="CR106">106</xref>&#x02013;<xref ref-type="bibr" rid="CR109">109</xref>]. Additionally, it has been shown that the prevalence of MDR-TB among new TB cases increased from 12% in 2009 to 13.7% in 2010 in the EU. Thus, drug-resistant TB is still a major concern despite a decrease in TB incidence in subsequent years [<xref ref-type="bibr" rid="CR110">110</xref>, <xref ref-type="bibr" rid="CR111">111</xref>].</p><p id="Par41">The use of antimicrobials as additives in plant agriculture (fruits, vegetables, orchids, etc.) and animals and, more importantly, food-producing animals can lead to the development of resistant bacteria [<xref ref-type="bibr" rid="CR112">112</xref>]. Thus, resistant genes in animals can be transferred to humans through the consumption of food or direct contact with food-producing animals or through environmental spread [<xref ref-type="bibr" rid="CR113">113</xref>&#x02013;<xref ref-type="bibr" rid="CR122">122</xref>]. The misuse of antimicrobials, especially in developing countries, is mainly due to their unregulated supply chain, the availability of over-the-counter drugs [<xref ref-type="bibr" rid="CR123">123</xref>&#x02013;<xref ref-type="bibr" rid="CR126">126</xref>], and self-medication [<xref ref-type="bibr" rid="CR125">125</xref>, <xref ref-type="bibr" rid="CR127">127</xref>&#x02013;<xref ref-type="bibr" rid="CR131">131</xref>], which is amplified by poverty [<xref ref-type="bibr" rid="CR131">131</xref>]. Up to half of all antibiotics prescribed are misused and neither needed nor effective [<xref ref-type="bibr" rid="CR132">132</xref>, <xref ref-type="bibr" rid="CR133">133</xref>]. Another situation is the discontinuation of treatment by patients with a recurrent infection, which contributes to the development of a virulent and resistant strain of the microbe [<xref ref-type="bibr" rid="CR130">130</xref>]. All these factors contribute to genetic selection pressure for the emergence of MDR bacterial infections in the community. Given the factors that contribute to the rise of AMR, reducing its risk implies the need to improve in ensuring the appropriate use of antibiotics through the enforcement and improvement of legislation on prescribing and dispensing antibiotics. In addition, the use of antibiotics in animal medicine and food production must be regulated. The government, pharmacists, doctors, veterinarians, and agronomists must work together and establish national guidelines for dispensing and prescribing antimicrobials. Adequate training on the proper prescription of antimicrobials must be given to health professionals, and the population must be educated on the use of antimicrobials and the threat of AMR.</p></sec><sec id="Sec7"><title>Host susceptibility</title><p id="Par42">Human susceptibility may influence the emergence of infectious diseases through genetic polymorphisms, impaired immune function, malnutrition, AIDS, immunosuppressive conditions, aging, and others. Innate and acquired immune defenses help humans to fight against infectious diseases. Genetic polymorphisms are potent natural selective forces for pathogens to induce human defenses against infection [<xref ref-type="bibr" rid="CR134">134</xref>&#x02013;<xref ref-type="bibr" rid="CR136">136</xref>]. People suffering from hemoglobinopathy S homozygosity develop more severe <italic>Plasmodium falciparum</italic> infection than those who have hemoglobin S heterozygotes [<xref ref-type="bibr" rid="CR136">136</xref>, <xref ref-type="bibr" rid="CR137">137</xref>]. Malnutrition also increases the severity of some infectious diseases. Thus, malnourished children have a higher risk of death from diarrhea, acute respiratory infections, and possibly malaria [<xref ref-type="bibr" rid="CR138">138</xref>]. According to the WHO, 26% of the world&#x02019;s malnourished children have been affected by population displacements, natural disasters, wars, civil disturbances, and population growth in the region [<xref ref-type="bibr" rid="CR139">139</xref>]. Considering immunosuppressive conditions, people who suffer from HIV/AIDS and cancers have a higher risk of increased disease severity. For example, the emergence of fungi, such as <italic>Aspergillus</italic> spp., and other opportunistic agents that were previously uncommon or unrecognized have increased in populations with cancer chemotherapy, organ, and tissue transplantation, or those infected with HIV [<xref ref-type="bibr" rid="CR140">140</xref>]. It has also been shown that more than 10% of cancers or transplants are either colonized or infected with vancomycin-resistant enterococci [<xref ref-type="bibr" rid="CR141">141</xref>].</p></sec><sec id="Sec8"><title>Behavior changes</title><p id="Par43">Human behavior has been an essential factor in the transmission of emerging infectious pathogens. Understanding community behavior during epidemics is key to improving control strategies [<xref ref-type="bibr" rid="CR142">142</xref>]. Behavior changes are often linked to culture, which refers to integrated patterns of human behavior that include the beliefs, language, communications, actions, and organizations of racial, ethnic, religious, or social groups [<xref ref-type="bibr" rid="CR143">143</xref>]. Many infectious disease outbreaks sensibly spread because of these factors. Since the occurrence of HIV/AIDS and Ebola, for example, stigmatization, discrimination, ignorance, trust, and misinformation have been the root of the spread of these diseases [<xref ref-type="bibr" rid="CR144">144</xref>&#x02013;<xref ref-type="bibr" rid="CR146">146</xref>].</p><p id="Par44">Another situation concerns human behavior changes related to conflicts. Conflicts of human behavior occur where people are interconnected, and they result from a variety of attitudes, needs, beliefs, and ways that humans react to different situations [<xref ref-type="bibr" rid="CR147">147</xref>]. Conflict situations can potentiate the (re)emergence and transmission of infectious diseases and are characterized by war or civil strife. This usually leads to the displacement of large populations, interruption of primary care and immunization programs, inadequate safe water supply, poor sanitation, and increased exposure to disease vectors [<xref ref-type="bibr" rid="CR67">67</xref>&#x02013;<xref ref-type="bibr" rid="CR69">69</xref>]. According to UNHCR, 70.8 million people around the world are forcibly displaced, constituting 41.3 million internally displaced people, 25.9 million refugees, and 3.5 million asylum-seekers [<xref ref-type="bibr" rid="CR70">70</xref>] from Africa to the Middle East, South Asia, and Europe [<xref ref-type="bibr" rid="CR148">148</xref>, <xref ref-type="bibr" rid="CR149">149</xref>]. Millions of people live in deplorable conditions, and healthcare facilities in host countries are overburdened; these conditions are suitable for the (re)emergence of infectious diseases [<xref ref-type="bibr" rid="CR70">70</xref>, <xref ref-type="bibr" rid="CR150">150</xref>]. Displaced populations are prone to viral and bacterial respiratory infections, nosocomial antibiotic-resistant bacterial infections, cholera, cutaneous leishmaniasis, sexually transmitted infections, poliomyelitis, Chagas, schistosomiasis, hepatitis B and C, meningococcal infections, and VBDs [<xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR151">151</xref>&#x02013;<xref ref-type="bibr" rid="CR154">154</xref>]. It would be better to (1) strengthen health systems in all countries; (2) evaluate the detection, containment, treatment and control of infectious diseases, including the implementation of surveillance systems; and (3) devise strategies for epidemics and protect health-supporting infrastructure and health workers during conflict situations and the aftermath, ultimately striving to achieve health equity by key policy actors [<xref ref-type="bibr" rid="CR68">68</xref>, <xref ref-type="bibr" rid="CR81">81</xref>, <xref ref-type="bibr" rid="CR151">151</xref>, <xref ref-type="bibr" rid="CR155">155</xref>, <xref ref-type="bibr" rid="CR156">156</xref>].</p></sec><sec id="Sec9"><title>Factors related to the spread of COVID-19</title><p id="Par45">COVID-19 is caused by a virus officially named severe acute respiratory syndrome coronavirus-2 (SARS-Cov-2) [<xref ref-type="bibr" rid="CR157">157</xref>, <xref ref-type="bibr" rid="CR158">158</xref>]. It is a new pandemic that started in December 2019 in Wuhan, Hubei Province of China [<xref ref-type="bibr" rid="CR159">159</xref>&#x02013;<xref ref-type="bibr" rid="CR161">161</xref>]. The disease rapidly spread from Wuhan to the rest of Mainland China and other parts of the world, affecting at least 216 countries and territories, with 15,745,102 confirmed cases and 639,317 confirmed deaths as of 26 July 2020 [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR162">162</xref>, <xref ref-type="bibr" rid="CR163">163</xref>]. Countries are reacting differently regarding the WHO-recommended preventive measures (lockdown, test-trace isolation, wearing masks and wearing them correctly, covering the mouth when coughing and sneezing, keeping at least one meter of social distance, frequent washing of hands and avoiding direct contact of the eyes, nose, and mouth [<xref ref-type="bibr" rid="CR164">164</xref>]), making some countries more affected than others. Therefore, the variation in the severity, frequency, and amplitude of this pandemic is due to the addition of several factors as well as government policies.</p><p id="Par46">Human behavior is an essential determinant of the transmission and spread of COVID-19 because the pandemic is spread by individual movements through large droplets and contacts, and possibly by aerosols and fomites, from person to person with direct or indirect contact based on the experience with SARS-CoV and MERS-CoV [<xref ref-type="bibr" rid="CR165">165</xref>&#x02013;<xref ref-type="bibr" rid="CR167">167</xref>]. Self-protection may be the critical determinant for the prevention of COVID-19 [<xref ref-type="bibr" rid="CR168">168</xref>] from one person to another because when a person protects himself or herself, he or she also protects others. Thus, understanding the collective behavior between and within individual groups would be useful for decision-making. Behavioral differences regarding COVID-19 containment measures such as lockdowns, social distancing, and the use of facial masks may cause some individuals to be more at risk than others and some countries to be more affected than others. Community behavior regarding preventive measures is influenced by cultural habits and misinformation. For example, there was also a great deal of misinformation and rumors that were widespread among the Chinese population and abroad with regard to the virus origin [<xref ref-type="bibr" rid="CR169">169</xref>&#x02013;<xref ref-type="bibr" rid="CR172">172</xref>], transmission mode, treatment, prevention, and control measures [<xref ref-type="bibr" rid="CR173">173</xref>, <xref ref-type="bibr" rid="CR174">174</xref>]. In addition, the WHO also created misinformation at the beginning of the pandemic by restricting the wearing of masks only to sick people showing symptoms and those who are caring for people with suspected infection [<xref ref-type="bibr" rid="CR175">175</xref>]. Thus, some countries advised populations to wear masks only in enclosed spaces such as shops or public transport. Additionally, misinformation created from social media and websites with no credible evidence has generated changes in the behavior of many people, increasing the frequency and spread of COVID-19 locally, regionally, and internationally [<xref ref-type="bibr" rid="CR176">176</xref>, <xref ref-type="bibr" rid="CR177">177</xref>]. In some countries, such as Japan, Singapore, China, and South Korea, cultural habits&#x02014;such as the culture of mask-wearing, minimal personal contact, improved hand sanitization, and fanciful suggestions that Japanese speakers emit fewer potentially virus-laden droplets when talking than do speakers of other languages&#x02014;have helped to flatten the curve and to limit the spread of COVID-19 in communities [<xref ref-type="bibr" rid="CR178">178</xref>, <xref ref-type="bibr" rid="CR179">179</xref>]. On the other hand, in Western countries such as Italy, Spain, the United States, the United Kingdom, France, and many other countries where the culture of mask-wearing is not a habit and where hugging, kissing, shaking hands, spending time together, and engaging in other social practices are common, the virus has spread quickly [<xref ref-type="bibr" rid="CR180">180</xref>, <xref ref-type="bibr" rid="CR181">181</xref>].</p><p id="Par47">Another factor is the lack of transparency from government, and politicization of this outbreak by politicians has created confusion among communities and urged people not to follow prevention and control measures such as early detection, isolation, and treatment of cases, contact tracing, and containment measures in communities to prevent disease transmission within and between societies.</p><p id="Par48">Host susceptibility includes aged individuals and other individuals with compromised immunity (such as high blood pressure, HIV, kidney diseases, diabetes, and cancers) who face higher risks of COVID-19 [<xref ref-type="bibr" rid="CR182">182</xref>&#x02013;<xref ref-type="bibr" rid="CR184">184</xref>]. Immune-compromised individuals are in a highly susceptible group, as their host defense is indigent; their defenses are already down, which could result in an increasingly poor prognosis for them [<xref ref-type="bibr" rid="CR182">182</xref>]. Atmospheric temperature variation also plays a role in the spread of COVID-19. It is known that winter is the flu season in cold temperate countries because influenza viruses survive better in cold-dry weather with reduced ultraviolet light. Reduced innate immunity is due to low levels of vitamin D and melatonin and to staying indoors frequently during winter, increasing opportunities for the virus to spread among people [<xref ref-type="bibr" rid="CR185">185</xref>, <xref ref-type="bibr" rid="CR186">186</xref>]. COVID-19 started during winter, and it has been shown that the local immune response in the nasal passage is reduced in people during cold winter, making them more susceptible to flu-like viruses [<xref ref-type="bibr" rid="CR186">186</xref>]. This situation may make people living in such areas more vulnerable than those living in tropical areas, leading to differences in the spatial distribution of COVID-19 worldwide.</p><p id="Par49">High temperature may be a protective factor, as it can provoke the evaporation of respiratory droplets, reducing infectivity [<xref ref-type="bibr" rid="CR187">187</xref>&#x02013;<xref ref-type="bibr" rid="CR189">189</xref>]. African and Asian tropical countries where high temperatures and high relative humidity are common may be protected from COVID-19 because of their negative effect on the spread of the disease. On the other hand, in Western countries where there are low temperatures and high humidity, its transmission in air-conditioned and temperate climatic environments may be facilitated [<xref ref-type="bibr" rid="CR187">187</xref>, <xref ref-type="bibr" rid="CR189">189</xref>]. Closed areas with low airflow and ventilation have been shown to play a role in the increasing risk of COVID-19 infection [<xref ref-type="bibr" rid="CR162">162</xref>], which makes developed countries at greater risk than developing countries. For instance, in developing countries, apart from some places in large cities, most people live under more natural atmospheric temperatures than do people in Western countries, where most houses are built with air-conditioning systems. Living in air-conditioned housing in addition to other factors, such as being older, having respiratory diseases or diabetes, or being an immune-compromised person, may increase the risk of transmission of COVID-19 [<xref ref-type="bibr" rid="CR190">190</xref>&#x02013;<xref ref-type="bibr" rid="CR193">193</xref>].</p><p id="Par50">High population density has also been associated with the spread of epidemics, including COVID-19 [<xref ref-type="bibr" rid="CR194">194</xref>]. In the case of COVID-19, a high number of cases have been observed in overcrowded cities in countries such as China, Japan, India, and the United States. Additionally, countries with a high proportion of elderly populations, such as Italy and Spain, have a higher risk of severity [<xref ref-type="bibr" rid="CR181">181</xref>], and this risk increases when young and older people live together [<xref ref-type="bibr" rid="CR195">195</xref>].</p><p id="Par51">International travel and trade have facilitated the spread of COVID-19. In the past, humanity has survived previous pandemics by infectious agents such as influenza viruses. However, the present one is unprecedented in its capacity to take advantage of modern globalization, allowing for the massive transborder spread at a surprising speed [<xref ref-type="bibr" rid="CR196">196</xref>]. With the current international travel and trade, it has been quite difficult to contain the spread of this virus. Countries have tried to impose travel restrictions and have reduced the exportation rate from mainland China, but these restrictions are insufficient to contain the geographic spread. Such measures have led to discrimination against foreigners [<xref ref-type="bibr" rid="CR197">197</xref>]. However, travel restrictions cannot be expected to fully apprehend the global expansion of COVID-19 but may decrease the rate of case exports if enacted during the early stages of the epidemic. This is because the onset of symptoms at the time of arrival is, in most cases, not detectable as the virus is still under incubation period [<xref ref-type="bibr" rid="CR198">198</xref>].</p><p id="Par52">Delayed government response, inadequate infrastructures, and lack of biosafety and biosecurity awareness have also contributed to the transmission and spread of COVID-19. Most countries have facilitated the transmission and spread of the disease due to inadequate preventive and/or mitigating strategies. Many countries failed to prevent the epidemic in the beginning by delaying preventive measures. However, a few countries succeeded in controlling the outbreak by adopting an effective mitigating strategy. South Korea and other countries, such as Singapore, Hong Kong, Japan, and Germany, quickly responded after the first case by adopting a strategy involving the testing and isolation of cases, contact tracing, and quarantining of suspected cases to suppress the full transmission of the virus in communities [<xref ref-type="bibr" rid="CR199">199</xref>]. Additionally, countries that have experienced SARS-like epidemics such as Taiwan, Hong Kong, and South Korea have successfully prevented the spread of COVID-19 from China by adopting preventive measures such as travel bans, closing of borders to nonresidents, and 14-day quarantines [<xref ref-type="bibr" rid="CR200">200</xref>]. Regarding lockdown measures, in the beginning, some countries delayed adopting this strategy because they sought to prevent harm to their economy (including some developed and developing countries) and because of poverty, especially in developing countries, where people are forced to go out as they need to work for their daily livelihood.</p><p id="Par53">Inadequate infrastructures and equipment and lack of awareness regarding laboratory biosafety and biosecurity in certain countries, especially in developing countries, have contributed to the spread of the disease in hospitals. Handling pathogens, especially viruses, may expose health workers to a high risk of contamination if they are not well trained. Thus, to prevent nosocomial infections, sufficient training of health workers in the principles and procedures of good laboratory practice (GLP) is needed. Health workers should be well trained on biohazards and the safe management of biological agents in the laboratory. Laboratory workers must have sufficient knowledge and experience about how to handle emerging pathogens safely and securely [<xref ref-type="bibr" rid="CR201">201</xref>, <xref ref-type="bibr" rid="CR202">202</xref>]. However, good awareness of GLPs must be reinforced by the availability of adequate equipment and infrastructures. In many countries, health professionals are working without PPE and are exposed to the infection. Thus, the lack of awareness about COVID-19 preventive measures cause health workers to be exposed and become infected. Additionally, the lack of testing kits, ventilators, and other equipment is impeding some countries from adopting an effective testing and tracing strategy and preventing deaths among severe cases.</p></sec></sec><sec id="Sec10"><title>Conclusions</title><p id="Par54">Human activities are still the significant determinants of the transmission and spread of (re)emerging infectious diseases. To date, we are still dealing with the COVID-19 pandemic, and it is challenging to predict when it will end. However, it is possible to face the disease or to reduce the risk of its transmission and spread by changing human behavior and implementing better early warning systems and effective disease control and prevention. Thus, effective global surveillance, global political will, and multidisciplinary collaboration of all stakeholders will be helpful in responding to any future threats.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>AIDS</term><def><p id="Par2">Acquired immunodeficiency syndrome</p></def></def-item><def-item><term>AMR</term><def><p id="Par3">Antimicrobial resistance</p></def></def-item><def-item><term>CA-MRSA</term><def><p id="Par4">Community-associated methicillin-resistant Staphylococcus aureus</p></def></def-item><def-item><term>CDC</term><def><p id="Par5">Centers for Disease Control and Prevention</p></def></def-item><def-item><term>COVID-19</term><def><p id="Par6">Coronavirus disease 2019</p></def></def-item><def-item><term>CTX-M</term><def><p id="Par7">Cefotaxime-M</p></def></def-item><def-item><term>DRC</term><def><p id="Par8">The Democratic Republic of the Congo</p></def></def-item><def-item><term>EIDs</term><def><p id="Par9">Emerging infectious diseases</p></def></def-item><def-item><term>EVD</term><def><p id="Par10">Ebola virus disease</p></def></def-item><def-item><term>FWBDs</term><def><p id="Par11">Food- and water-borne diseases</p></def></def-item><def-item><term>HIV</term><def><p id="Par12">Human immunodeficiency virus</p></def></def-item><def-item><term>MARS</term><def><p id="Par13">Middle East respiratory syndrome</p></def></def-item><def-item><term>MDR</term><def><p id="Par14">Multidrug-resistant</p></def></def-item><def-item><term>MRSA</term><def><p id="Par15">Methicillin-resistant <italic>Staphylococcus aureus</italic></p></def></def-item><def-item><term>SARS</term><def><p id="Par16">Severe acute respiratory syndrome</p></def></def-item><def-item><term>SDGs</term><def><p id="Par17">Sustainable Development Goals</p></def></def-item><def-item><term>TB</term><def><p id="Par18">Tuberculosis</p></def></def-item><def-item><term>EU</term><def><p id="Par19">European Union</p></def></def-item><def-item><term>UK</term><def><p id="Par20">United Kingdom of Great Britain and Northern Ireland</p></def></def-item><def-item><term>UNHCR</term><def><p id="Par21">The Office of the United Nations High Commissioner for Refugees</p></def></def-item><def-item><term>US</term><def><p id="Par22">The United States</p></def></def-item><def-item><term>VBDs</term><def><p id="Par23">Vector-borne diseases</p></def></def-item><def-item><term>WHO</term><def><p id="Par24">World Health Organization</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher&#x02019;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>Not applicable.</p></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>NSS and TY participated in the design of the study; NSS, ASC, and SVS searched the literature, selected the reviewed articles, and wrote the draft of the manuscript. HA, HI, and TN also contributed to the design of the study and wrote the manuscript. All authors approved the final version of the manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This work was supported by Grants-in-Aid for Scientific Research (KAKENHI No. JP19K24679) from the Japan Society for the Promotion of Science.</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>Not applicable.</p></notes><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par55">Not applicable.</p></notes><notes id="FPar2"><title>Consent for publication</title><p id="Par56">Not applicable.</p></notes><notes id="FPar3" notes-type="COI-statement"><title>Competing interests</title><p id="Par57">The authors declare that they have no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><source>Division of emerging other communicable diseases surveillance control emerging infectious diseases</source><year>1997</year><publisher-loc>Geneva</publisher-loc><publisher-name>World Health Organization</publisher-name></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mackey</surname><given-names>TK</given-names></name><name><surname>Liang</surname><given-names>BA</given-names></name></person-group><article-title>Lessons from SARS and H1N1/A: employing a WHO-WTO forum to promote optimal economic-public health pandemic response</article-title><source>J Public Health Policy</source><year>2012</year><volume>33</volume><fpage>119</fpage><lpage>130</lpage><?supplied-pmid 22048060?><pub-id pub-id-type="pmid">22048060</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woolhouse</surname><given-names>ME</given-names></name><name><surname>Taylor</surname><given-names>LH</given-names></name><name><surname>Haydon</surname><given-names>DT</given-names></name></person-group><article-title>Population biology of multihost pathogens</article-title><source>Science.</source><year>2001</year><volume>292</volume><fpage>1109</fpage><lpage>1112</lpage><?supplied-pmid 11352066?><pub-id pub-id-type="pmid">11352066</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slingenbergh</surname><given-names>JI</given-names></name><name><surname>Gilbert</surname><given-names>M</given-names></name><name><surname>de Balogh</surname><given-names>KI</given-names></name><name><surname>Wint</surname><given-names>W</given-names></name></person-group><article-title>Ecological sources of zoonotic diseases</article-title><source>Rev Sci Tech</source><year>2004</year><volume>23</volume><fpage>467</fpage><lpage>484</lpage><?supplied-pmid 15702714?><pub-id pub-id-type="pmid">15702714</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heymann</surname><given-names>DL</given-names></name><name><surname>Dixon</surname><given-names>M</given-names></name></person-group><article-title>Infections at the animal/human interface: shifting the paradigm from emergency response to prevention at source</article-title><source>Curr Top Microbiol Immunol</source><year>2013</year><volume>366</volume><fpage>207</fpage><lpage>215</lpage><?supplied-pmid 23239233?><pub-id pub-id-type="pmid">23239233</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>BA</given-names></name><name><surname>Grace</surname><given-names>D</given-names></name><name><surname>Kock</surname><given-names>R</given-names></name><name><surname>Alonso</surname><given-names>S</given-names></name><name><surname>Rushton</surname><given-names>J</given-names></name><name><surname>Said</surname><given-names>MY</given-names></name><etal/></person-group><article-title>Zoonosis emergence linked to agricultural intensification and environmental change</article-title><source>Proc Natl Acad Sci U S A</source><year>2013</year><volume>110</volume><fpage>8399</fpage><lpage>8404</lpage><?supplied-pmid 23671097?><pub-id pub-id-type="pmid">23671097</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>KE</given-names></name><name><surname>Patel</surname><given-names>NG</given-names></name><name><surname>Levy</surname><given-names>MA</given-names></name><name><surname>Storeygard</surname><given-names>A</given-names></name><name><surname>Balk</surname><given-names>D</given-names></name><name><surname>Gittleman</surname><given-names>JL</given-names></name><etal/></person-group><article-title>Global trends in emerging infectious diseases</article-title><source>Nature.</source><year>2008</year><volume>451</volume><fpage>990</fpage><lpage>993</lpage><?supplied-pmid 18288193?><pub-id pub-id-type="pmid">18288193</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>FA</given-names></name></person-group><article-title>Emerging zoonoses: the challenge for public health and biodefense</article-title><source>Prev Vet Med</source><year>2008</year><volume>86</volume><fpage>216</fpage><lpage>223</lpage><?supplied-pmid 18378340?><pub-id pub-id-type="pmid">18378340</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>LH</given-names></name><name><surname>Latham</surname><given-names>SM</given-names></name><name><surname>Woolhouse</surname><given-names>ME</given-names></name></person-group><article-title>Risk factors for human disease emergence</article-title><source>Philos Trans R Soc Lond Ser B Biol Sci</source><year>2001</year><volume>356</volume><fpage>983</fpage><lpage>989</lpage><pub-id pub-id-type="pmid">11516376</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Barry</surname><given-names>L</given-names></name></person-group><source>A national food-safety initiative : report to the president may 1997</source><year>1998</year><publisher-loc>Washington, DC</publisher-loc><publisher-name>National Academies Press</publisher-name></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marwick</surname><given-names>C</given-names></name></person-group><article-title>Investigators present latest findings on Hong Kong 'bird flu' to the FDA</article-title><source>JAMA.</source><year>1998</year><volume>279</volume><fpage>643</fpage><lpage>644</lpage><?supplied-pmid 9496966?><pub-id pub-id-type="pmid">9496966</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Centers for Disease Control Prevention</collab></person-group><article-title>Outbreak of West Nile-like viral encephalitis--New York, 1999</article-title><source>MMWR Morb Mortal Wkly Rep</source><year>1999</year><volume>48</volume><fpage>845</fpage><pub-id pub-id-type="pmid">10563521</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rezza</surname><given-names>G</given-names></name><name><surname>Nicoletti</surname><given-names>L</given-names></name><name><surname>Angelini</surname><given-names>R</given-names></name><name><surname>Romi</surname><given-names>R</given-names></name><name><surname>Finarelli</surname><given-names>AC</given-names></name><name><surname>Panning</surname><given-names>M</given-names></name><etal/></person-group><article-title>Infection with chikungunya virus in Italy: an outbreak in a temperate region</article-title><source>Lancet.</source><year>2007</year><volume>370</volume><fpage>1840</fpage><lpage>1846</lpage><?supplied-pmid 18061059?><pub-id pub-id-type="pmid">18061059</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Hoek</surname><given-names>W</given-names></name><name><surname>Dijkstra</surname><given-names>F</given-names></name><name><surname>Schimmer</surname><given-names>B</given-names></name><name><surname>Schneeberger</surname><given-names>PM</given-names></name><name><surname>Vellema</surname><given-names>P</given-names></name><name><surname>Wijkmans</surname><given-names>C</given-names></name><etal/></person-group><article-title>Q fever in the Netherlands: an update on the epidemiology and control measures</article-title><source>Euro Surveill</source><year>2010</year><volume>15</volume><fpage>19520</fpage><?supplied-pmid 20350500?><pub-id pub-id-type="pmid">20350500</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Hoek</surname><given-names>W</given-names></name><name><surname>Morroy</surname><given-names>G</given-names></name><name><surname>Renders</surname><given-names>NH</given-names></name><name><surname>Wever</surname><given-names>PC</given-names></name><name><surname>Hermans</surname><given-names>MH</given-names></name><name><surname>Leenders</surname><given-names>AC</given-names></name><etal/></person-group><article-title>Epidemic Q fever in humans in the Netherlands</article-title><source>Adv Exp Med Biol</source><year>2012</year><volume>984</volume><fpage>329</fpage><lpage>364</lpage><?supplied-pmid 22711640?><pub-id pub-id-type="pmid">22711640</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="other">Severe acute respiratory syndrome (SARS). Wkly Epidemiol Rec. 2003;78:81&#x02013;3.</mixed-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pugliese</surname><given-names>A</given-names></name><name><surname>Beltramo</surname><given-names>T</given-names></name><name><surname>Torre</surname><given-names>D</given-names></name></person-group><article-title>Emerging and re-emerging viral infections in Europe</article-title><source>Cell Biochem Funct</source><year>2007</year><volume>25</volume><fpage>1</fpage><lpage>13</lpage><?supplied-pmid 16944546?><pub-id pub-id-type="pmid">16944546</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Snell</surname><given-names>NJ</given-names></name></person-group><article-title>Novel and re-emerging respiratory infections</article-title><source>Expert Rev Anti-Infect Ther</source><year>2004</year><volume>2</volume><fpage>405</fpage><lpage>412</lpage><?supplied-pmid 15482205?><pub-id pub-id-type="pmid">15482205</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="other">World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV). 2019. <ext-link ext-link-type="uri" xlink:href="https://www.who.int/en/news-room/fact-sheets/detail/middle-east-respiratory-syndrome-coronavirus-(mers-cov)">https://www.who.int/en/news-room/fact-sheets/detail/middle-east-respiratory-syndrome-coronavirus-(mers-cov)</ext-link>. Accessed 26 Jul 2020.</mixed-citation></ref><ref id="CR20"><label>20.</label><mixed-citation publication-type="other">World Health Organization. Influenza (avian and other zoonotic). 2018. <ext-link ext-link-type="uri" xlink:href="https://www.who.int/news-room/fact-sheets/detail/influenza-(avian-and-other-zoonotic)">https://www.who.int/news-room/fact-sheets/detail/influenza-(avian-and-other-zoonotic)</ext-link> . Accessed 26 Jul 2020.</mixed-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fouchier</surname><given-names>RA</given-names></name><name><surname>Schneeberger</surname><given-names>PM</given-names></name><name><surname>Rozendaal</surname><given-names>FW</given-names></name><name><surname>Broekman</surname><given-names>JM</given-names></name><name><surname>Kemink</surname><given-names>SA</given-names></name><name><surname>Munster</surname><given-names>V</given-names></name><etal/></person-group><article-title>Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome</article-title><source>Proc Natl Acad Sci U S A</source><year>2004</year><volume>101</volume><fpage>1356</fpage><lpage>1361</lpage><?supplied-pmid 14745020?><pub-id pub-id-type="pmid">14745020</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><mixed-citation publication-type="other">Avian influenza A/(H7N2) outbreak in the United Kingdom. Euro Surveill. 2007;12:E070531.2.</mixed-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>R</given-names></name><name><surname>Cao</surname><given-names>B</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Feng</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Hu</surname><given-names>W</given-names></name><etal/></person-group><article-title>Human infection with a novel avian-origin influenza A (H7N9) virus</article-title><source>N Engl J Med</source><year>2013</year><volume>368</volume><fpage>1888</fpage><lpage>1897</lpage><?supplied-pmid 23577628?><pub-id pub-id-type="pmid">23577628</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><mixed-citation publication-type="other">World Health Organization. Ebola situation report. 2016. <ext-link ext-link-type="uri" xlink:href="https://apps.who.int/ebola/current-situation/ebola-situation-report-16-march-2016">https://apps.who.int/ebola/current-situation/ebola-situation-report-16-march-2016</ext-link>. Accessed 26 Jul 2020.</mixed-citation></ref><ref id="CR25"><label>25.</label><mixed-citation publication-type="other">World Health Organization. Ebola virus disease? Democratic republic of the Congo. 2020. <ext-link ext-link-type="uri" xlink:href="https://www.who.int/csr/don/12-March-2020-ebola-drc/en/">https://www.who.int/csr/don/12-March-2020-ebola-drc/en/</ext-link>. Accessed 16 Jul 2020.</mixed-citation></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="other">World Health Organization. Coronavirus disease (COVID-2019) situation reports. 2020. <ext-link ext-link-type="uri" xlink:href="https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports">https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports</ext-link>. Accessed 26 Jul 2020.</mixed-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolfe</surname><given-names>ND</given-names></name><name><surname>Dunavan</surname><given-names>CP</given-names></name><name><surname>Diamond</surname><given-names>J</given-names></name></person-group><article-title>Origins of major human infectious diseases</article-title><source>Nature.</source><year>2007</year><volume>447</volume><fpage>279</fpage><lpage>283</lpage><?supplied-pmid 17507975?><pub-id pub-id-type="pmid">17507975</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Snieszko</surname><given-names>SF</given-names></name></person-group><article-title>The effects of environmental stress on outbreaks of infectious diseases of fishes</article-title><source>J Fish Biol</source><year>1974</year><volume>6</volume><fpage>197</fpage><lpage>208</lpage></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lederberg</surname><given-names>J</given-names></name><name><surname>Hamburg</surname><given-names>MA</given-names></name><name><surname>Smolinski</surname><given-names>MS</given-names></name></person-group><source>Microbial threats to health: emergence, detection, and response</source><year>2003</year><publisher-loc>Washington, DC</publisher-loc><publisher-name>National Academies Press</publisher-name></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chareonsook</surname><given-names>O</given-names></name><name><surname>Foy</surname><given-names>HM</given-names></name><name><surname>Teeraratkul</surname><given-names>A</given-names></name><name><surname>Silarug</surname><given-names>N</given-names></name></person-group><article-title>Changing epidemiology of dengue hemorrhagic fever in Thailand</article-title><source>Epidemiol Infect</source><year>1999</year><volume>122</volume><fpage>161</fpage><lpage>166</lpage><?supplied-pmid 10098800?><pub-id pub-id-type="pmid">10098800</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frieden</surname><given-names>TR</given-names></name><name><surname>Tappero</surname><given-names>JW</given-names></name><name><surname>Dowell</surname><given-names>SF</given-names></name><name><surname>Hien</surname><given-names>NT</given-names></name><name><surname>Guillaume</surname><given-names>FD</given-names></name><name><surname>Aceng</surname><given-names>JR</given-names></name></person-group><article-title>Safer countries through global health security</article-title><source>Lancet.</source><year>2014</year><volume>383</volume><fpage>764</fpage><lpage>766</lpage><?supplied-pmid 24529561?><pub-id pub-id-type="pmid">24529561</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><mixed-citation publication-type="other">World Health Organization. Globalization and infectious diseases: a review of the linkages. 2004. <ext-link ext-link-type="uri" xlink:href="https://www.who.int/tdr/publications/documents/seb_topic3.pdf">https://www.who.int/tdr/publications/documents/seb_topic3.pdf</ext-link>. Accessed 26 Jul 2020.</mixed-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oshitani</surname><given-names>H</given-names></name></person-group><article-title>Globalization and emerging infectious diseases</article-title><source>Nihon Rinsho</source><year>2016</year><volume>74</volume><fpage>1956</fpage><lpage>1961</lpage><?supplied-pmid 30550649?><pub-id pub-id-type="pmid">30550649</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vignier</surname><given-names>N</given-names></name><name><surname>Bouchaud</surname><given-names>O</given-names></name></person-group><article-title>Travel, migration and emerging infectious diseases</article-title><source>EJIFCC.</source><year>2018</year><volume>29</volume><fpage>175</fpage><lpage>179</lpage><?supplied-pmid 30479600?><pub-id pub-id-type="pmid">30479600</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delisle</surname><given-names>E</given-names></name><name><surname>Rousseau</surname><given-names>C</given-names></name><name><surname>Broche</surname><given-names>B</given-names></name><name><surname>Leparc-Goffart</surname><given-names>I</given-names></name><name><surname>L'Ambert</surname><given-names>G</given-names></name><name><surname>Cochet</surname><given-names>A</given-names></name><etal/></person-group><article-title>Chikungunya outbreak in Montpellier, France, September to October 2014</article-title><source>Euro Surveill</source><year>2015</year><volume>20</volume><fpage>21108</fpage><?supplied-pmid 25955774?><pub-id pub-id-type="pmid">25955774</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><mixed-citation publication-type="other">Jacob E. Coronavirus: trois premiers cas confirmes en France, deux d'entre eux vont bien. 2020. <ext-link ext-link-type="uri" xlink:href="https://www.lefigaro.fr/sciences/coronavirus-trois-premiers-cas-confirmes-en-france-20200124">https://www.lefigaro.fr/sciences/coronavirus-trois-premiers-cas-confirmes-en-france-20200124</ext-link>. Accessed 26 Jul 2020.</mixed-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marchand</surname><given-names>E</given-names></name><name><surname>Prat</surname><given-names>C</given-names></name><name><surname>Jeannin</surname><given-names>C</given-names></name><name><surname>Lafont</surname><given-names>E</given-names></name><name><surname>Bergmann</surname><given-names>T</given-names></name><name><surname>Flusin</surname><given-names>O</given-names></name><etal/></person-group><article-title>Autochthonous case of dengue in France, October 2013</article-title><source>Euro Surveill</source><year>2013</year><volume>18</volume><fpage>20661</fpage><?supplied-pmid 24342514?><pub-id pub-id-type="pmid">24342514</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van den Berg</surname><given-names>T</given-names></name></person-group><article-title>The role of the legal and illegal trade of live birds and avian products in the spread of avian influenza</article-title><source>Rev Sci Tech</source><year>2009</year><volume>28</volume><fpage>93</fpage><lpage>111</lpage><?supplied-pmid 19618621?><pub-id pub-id-type="pmid">19618621</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><mixed-citation publication-type="other">World Health Organization. International health regulations (2005). 2016. <ext-link ext-link-type="uri" xlink:href="https://www.who.int/ihr/publications/9789241580496/en/">https://www.who.int/ihr/publications/9789241580496/en/</ext-link>. Accessed 26 Jul 2020.</mixed-citation></ref><ref id="CR40"><label>40.</label><mixed-citation publication-type="other">World Trade Organization. WTO agreements &#x00026; public health: a joint study by the WHO and the WTO Secretariat. 2002. <ext-link ext-link-type="uri" xlink:href="https://www.wto.org/english/res_e/booksp_e/who_wto_e.pdf">https://www.wto.org/english/res_e/booksp_e/who_wto_e.pdf</ext-link>. Accessed 26 Jul 2020.</mixed-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chinazzi</surname><given-names>M</given-names></name><name><surname>Davis</surname><given-names>JT</given-names></name><name><surname>Ajelli</surname><given-names>M</given-names></name><name><surname>Gioannini</surname><given-names>C</given-names></name><name><surname>Litvinova</surname><given-names>M</given-names></name><name><surname>Merler</surname><given-names>S</given-names></name><etal/></person-group><article-title>The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak</article-title><source>Science.</source><year>2020</year><volume>368</volume><fpage>395</fpage><lpage>400</lpage><?supplied-pmid 32144116?><pub-id pub-id-type="pmid">32144116</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferguson</surname><given-names>NM</given-names></name><name><surname>Cummings</surname><given-names>DA</given-names></name><name><surname>Fraser</surname><given-names>C</given-names></name><name><surname>Cajka</surname><given-names>JC</given-names></name><name><surname>Cooley</surname><given-names>PC</given-names></name><name><surname>Burke</surname><given-names>DS</given-names></name></person-group><article-title>Strategies for mitigating an influenza pandemic</article-title><source>Nature.</source><year>2006</year><volume>442</volume><fpage>448</fpage><lpage>452</lpage><?supplied-pmid 16642006?><pub-id pub-id-type="pmid">16642006</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mateus</surname><given-names>AL</given-names></name><name><surname>Otete</surname><given-names>HE</given-names></name><name><surname>Beck</surname><given-names>CR</given-names></name><name><surname>Dolan</surname><given-names>GP</given-names></name><name><surname>Nguyen-Van-Tam</surname><given-names>JS</given-names></name></person-group><article-title>Effectiveness of travel restrictions in the rapid containment of human influenza: a systematic review</article-title><source>Bull World Health Organ</source><year>2014</year><volume>92</volume><fpage>868</fpage><lpage>80D</lpage><?supplied-pmid 25552771?><pub-id pub-id-type="pmid">25552771</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><mixed-citation publication-type="other">Wood JG, Zamani N, MacIntyre CR. Effects of internal border control on spread of pandemic influenza. 2010. <ext-link ext-link-type="uri" xlink:href="https://www.nc.cdc.gov/eid/article/13/7/06-0740_article">https://www.nc.cdc.gov/eid/article/13/7/06-0740_article</ext-link>. Accessed 26 Jul 2020.</mixed-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torner</surname><given-names>N</given-names></name></person-group><article-title>Risky trade: infectious disease in the era of global trade</article-title><source>J Epidemiol Community Health</source><year>2007</year><volume>61</volume><fpage>926</fpage></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hautier</surname><given-names>Y</given-names></name><name><surname>Tilman</surname><given-names>D</given-names></name><name><surname>Isbell</surname><given-names>F</given-names></name><name><surname>Seabloom</surname><given-names>EW</given-names></name><name><surname>Borer</surname><given-names>ET</given-names></name><name><surname>Reich</surname><given-names>PB</given-names></name></person-group><article-title>Plant ecology. Anthropogenic environmental changes affect ecosystem stability via biodiversity</article-title><source>Science.</source><year>2015</year><volume>348</volume><fpage>336</fpage><lpage>340</lpage><?supplied-pmid 25883357?><pub-id pub-id-type="pmid">25883357</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><mixed-citation publication-type="other">World Health Organization. Global environmental change. 2020. <ext-link ext-link-type="uri" xlink:href="https://www.who.int/globalchange/environment/en/">https://www.who.int/globalchange/environment/en/</ext-link>. Accessed 26 Jul 2020.</mixed-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>National Academy of Sciences</collab></person-group><source>Infectious disease emergence: microbial evolution and co-adaptation</source><year>2009</year><publisher-loc>England</publisher-loc><publisher-name>National Academies Press</publisher-name></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nava</surname><given-names>A</given-names></name><name><surname>Shimabukuro</surname><given-names>JS</given-names></name><name><surname>Chmura</surname><given-names>AA</given-names></name><name><surname>Luz</surname><given-names>SLB</given-names></name></person-group><article-title>The impact of global environmental changes on infectious disease emergence with a focus on risks for Brazil</article-title><source>ILAR J</source><year>2017</year><volume>58</volume><fpage>393</fpage><lpage>400</lpage><?supplied-pmid 29253158?><pub-id pub-id-type="pmid">29253158</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morens</surname><given-names>DM</given-names></name><name><surname>Fauci</surname><given-names>AS</given-names></name></person-group><article-title>Emerging infectious diseases: threats to human health and global stability</article-title><source>PLoS Pathog</source><year>2013</year><volume>9</volume><fpage>e1003467</fpage><?supplied-pmid 23853589?><pub-id pub-id-type="pmid">23853589</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morse</surname><given-names>SS</given-names></name></person-group><article-title>Factors and determinants of disease emergence</article-title><source>Rev Sci Tech</source><year>2004</year><volume>23</volume><fpage>443</fpage><lpage>451</lpage><?supplied-pmid 15702712?><pub-id pub-id-type="pmid">15702712</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galvani</surname><given-names>AP</given-names></name><name><surname>Bauch</surname><given-names>CT</given-names></name><name><surname>Anand</surname><given-names>M</given-names></name><name><surname>Singer</surname><given-names>BH</given-names></name><name><surname>Levin</surname><given-names>SA</given-names></name></person-group><article-title>Human-environment interactions in population and ecosystem health</article-title><source>Proc Natl Acad Sci U S A</source><year>2016</year><volume>113</volume><fpage>14502</fpage><lpage>14506</lpage><?supplied-pmid 27956616?><pub-id pub-id-type="pmid">27956616</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Semenza</surname><given-names>JC</given-names></name><name><surname>Ebi</surname><given-names>KL</given-names></name></person-group><article-title>Climate change impact on migration, travel, travel destinations and the tourism industry</article-title><source>J Travel Med</source><year>2019</year><volume>26</volume><fpage>taz026</fpage><?supplied-pmid 30976790?><pub-id pub-id-type="pmid">30976790</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Xu</surname><given-names>B</given-names></name></person-group><article-title>Impact of climate change on human infectious diseases: empirical evidence and human adaptation</article-title><source>Environ Int</source><year>2016</year><volume>86</volume><fpage>14</fpage><lpage>23</lpage><?supplied-pmid 26479830?><pub-id pub-id-type="pmid">26479830</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><mixed-citation publication-type="other">UNHCR. Environment, disasters and climate change. 2020. <ext-link ext-link-type="uri" xlink:href="http://www.unhcr.org/environment-disasters-and-climate-change.html">http://www.unhcr.org/environment-disasters-and-climate-change.html</ext-link>. Accessed 26 Jul 2020.</mixed-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbour</surname><given-names>AG</given-names></name><name><surname>Fish</surname><given-names>D</given-names></name></person-group><article-title>The biological and social phenomenon of Lyme disease</article-title><source>Science.</source><year>1993</year><volume>260</volume><fpage>1610</fpage><lpage>1616</lpage><?supplied-pmid 8503006?><pub-id pub-id-type="pmid">8503006</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Cisse</surname><given-names>G</given-names></name><name><surname>Alves</surname><given-names>MJ</given-names></name><name><surname>Confalonieri</surname><given-names>U</given-names></name></person-group><person-group person-group-type="editor"><name><surname>UNEP</surname></name></person-group><article-title>Climate-sensitive infectious diseases</article-title><source>The adaptation gap report 2018</source><year>2018</year><publisher-loc>Nairobi</publisher-loc><publisher-name>UNEP</publisher-name><fpage>49</fpage><lpage>59</lpage></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McIntyre</surname><given-names>KM</given-names></name><name><surname>Setzkorn</surname><given-names>C</given-names></name><name><surname>Hepworth</surname><given-names>PJ</given-names></name><name><surname>Morand</surname><given-names>S</given-names></name><name><surname>Morse</surname><given-names>AP</given-names></name><name><surname>Baylis</surname><given-names>M</given-names></name></person-group><article-title>Systematic assessment of the climate sensitivity of important human and domestic animals pathogens in Europe</article-title><source>Sci Rep</source><year>2017</year><volume>7</volume><fpage>7134</fpage><?supplied-pmid 28769039?><pub-id pub-id-type="pmid">28769039</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><source>Vector-borne diseases</source><year>2020</year><publisher-loc>Geneva</publisher-loc><publisher-name>World Health Organization</publisher-name></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caminade</surname><given-names>C</given-names></name><name><surname>McIntyre</surname><given-names>KM</given-names></name><name><surname>Jones</surname><given-names>AE</given-names></name></person-group><article-title>Impact of recent and future climate change on vector-borne diseases</article-title><source>Ann N Y Acad Sci</source><year>2019</year><volume>1436</volume><fpage>157</fpage><lpage>173</lpage><?supplied-pmid 30120891?><pub-id pub-id-type="pmid">30120891</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>SY</given-names></name><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name></person-group><article-title>World outbreak trend of infectious diseases with surveillance</article-title><source>J Bacteriol</source><year>2019</year><volume>49</volume><fpage>141</fpage><lpage>151</lpage></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciota</surname><given-names>AT</given-names></name><name><surname>Keyel</surname><given-names>AC</given-names></name></person-group><article-title>The role of temperature in transmission of zoonotic arboviruses</article-title><source>Viruses.</source><year>2019</year><volume>11</volume><fpage>1013</fpage></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciss&#x000e9;</surname><given-names>G</given-names></name></person-group><article-title>Food-borne and water-borne diseases under climate change in low- and middle-income countries: further efforts needed for reducing environmental health exposure risks</article-title><source>Acta Trop</source><year>2019</year><volume>194</volume><fpage>181</fpage><lpage>188</lpage><?supplied-pmid 30946811?><pub-id pub-id-type="pmid">30946811</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fenollar</surname><given-names>F</given-names></name><name><surname>Mediannikov</surname><given-names>O</given-names></name></person-group><article-title>Emerging infectious diseases in Africa in the 21st century</article-title><source>New Microbes New Infect</source><year>2018</year><volume>26</volume><fpage>S10</fpage><lpage>S18</lpage><?supplied-pmid 30402238?><pub-id pub-id-type="pmid">30402238</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morse</surname><given-names>SS</given-names></name></person-group><article-title>Factors in the emergence of infectious diseases</article-title><source>Emerg Infect Dis</source><year>1995</year><volume>1</volume><fpage>7</fpage><lpage>15</lpage><?supplied-pmid 8903148?><pub-id pub-id-type="pmid">8903148</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><mixed-citation publication-type="other">Department of Economic Social Affairs Disability. Envision2030: 17 goals to transform the world for persons with disabilities. 2020. <ext-link ext-link-type="uri" xlink:href="https://www.un.org/development/desa/disabilities/envision2030.html">https://www.un.org/development/desa/disabilities/envision2030.html</ext-link>. Accessed 26 Jul 2020.</mixed-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rockstr&#x000f6;m</surname><given-names>J</given-names></name><name><surname>Williams</surname><given-names>J</given-names></name><name><surname>Daily</surname><given-names>G</given-names></name><name><surname>Noble</surname><given-names>A</given-names></name><name><surname>Matthews</surname><given-names>N</given-names></name><name><surname>Gordon</surname><given-names>L</given-names></name><etal/></person-group><article-title>Sustainable intensification of agriculture for human prosperity and global sustainability</article-title><source>Ambio.</source><year>2017</year><volume>46</volume><fpage>4</fpage><lpage>17</lpage><?supplied-pmid 27405653?><pub-id pub-id-type="pmid">27405653</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rohr</surname><given-names>JR</given-names></name><name><surname>Barrett</surname><given-names>CB</given-names></name><name><surname>Civitello</surname><given-names>DJ</given-names></name><name><surname>Craft</surname><given-names>ME</given-names></name><name><surname>Delius</surname><given-names>B</given-names></name><name><surname>DeLeo</surname><given-names>GA</given-names></name><etal/></person-group><article-title>Emerging human infectious diseases and the links to global food production</article-title><source>Nat Sustain</source><year>2019</year><volume>2</volume><fpage>445</fpage><lpage>456</lpage><?supplied-pmid 32219187?><pub-id pub-id-type="pmid">32219187</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>HA</given-names></name><name><surname>Huxley</surname><given-names>P</given-names></name><name><surname>Elmes</surname><given-names>J</given-names></name><name><surname>Murray</surname><given-names>KA</given-names></name></person-group><article-title>Agricultural land-uses consistently exacerbate infectious disease risks in Southeast Asia</article-title><source>Nat Commun</source><year>2019</year><volume>10</volume><fpage>4299</fpage><?supplied-pmid 31541099?><pub-id pub-id-type="pmid">31541099</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer</surname><given-names>JD</given-names></name></person-group><article-title>Geography, ecology and emerging infectious diseases</article-title><source>Soc Sci Med</source><year>2000</year><volume>50</volume><fpage>937</fpage><lpage>952</lpage><?supplied-pmid 10714918?><pub-id pub-id-type="pmid">10714918</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morse</surname><given-names>SS</given-names></name><name><surname>Schluederberg</surname><given-names>A</given-names></name></person-group><article-title>From the national institute of allergy and infectious diseases, the fogarty international center of the national institutes of health, and the rockefeller university. Emerging viruses: the evolution of viruses and viral diseases</article-title><source>J Infect Dis</source><year>1990</year><volume>162</volume><fpage>1</fpage><lpage>7</lpage><?supplied-pmid 2113071?><pub-id pub-id-type="pmid">2113071</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolfe</surname><given-names>ND</given-names></name><name><surname>Daszak</surname><given-names>P</given-names></name><name><surname>Kilpatrick</surname><given-names>AM</given-names></name><name><surname>Burke</surname><given-names>DS</given-names></name></person-group><article-title>Bushmeat hunting, deforestation, and prediction of zoonotic disease</article-title><source>Emerg Infect Dis</source><year>2005</year><volume>11</volume><fpage>6</fpage><pub-id pub-id-type="pmid">15705315</pub-id></element-citation></ref><ref id="CR73"><label>73.</label><mixed-citation publication-type="other">Domestic animals and infectious diseases of man. J Am Med Assoc. 1902;XXXVIII:1520&#x02013;1.</mixed-citation></ref><ref id="CR74"><label>74.</label><mixed-citation publication-type="other">World Health Organization. Animal&#x02013;human interface for health. <ext-link ext-link-type="uri" xlink:href="https://www.who.int/myanmar/activities/animal%2D%2Dhuman-interface-for-health">https://www.who.int/myanmar/activities/animal%2D%2Dhuman-interface-for-health</ext-link>. Accessed 26 Jul 2020.</mixed-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roche</surname><given-names>B</given-names></name><name><surname>Gu&#x000e9;gan</surname><given-names>JF</given-names></name></person-group><article-title>Ecosystem dynamics, biological diversity and emerging infectious diseases</article-title><source>C R Biol</source><year>2011</year><volume>334</volume><fpage>385</fpage><lpage>392</lpage><?supplied-pmid 21640947?><pub-id pub-id-type="pmid">21640947</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Knobler</surname><given-names>S</given-names></name><name><surname>Mahmoud</surname><given-names>A</given-names></name><name><surname>Lemon</surname><given-names>S</given-names></name><name><surname>Pray</surname><given-names>L</given-names></name></person-group><source>The impact of globalization on infectious disease emergence and control exploring the consequences and opportunities workshop summary</source><year>2006</year><publisher-loc>Washington, DC</publisher-loc><publisher-name>National Academies Press</publisher-name></element-citation></ref><ref id="CR77"><label>77.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kurpiers</surname><given-names>LA</given-names></name><name><surname>Schulte-Herbr&#x000fc;ggen</surname><given-names>B</given-names></name><name><surname>Ejotre</surname><given-names>I</given-names></name><name><surname>Reeder</surname><given-names>DM</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Angelici</surname><given-names>FM</given-names></name></person-group><article-title>Bushmeat and emerging infectious diseases: lessons from africa</article-title><source>Problematic wildlife: a cross-disciplinary approach</source><year>2016</year><publisher-loc>Cham</publisher-loc><publisher-name>Springer International Publishing</publisher-name><fpage>507</fpage><lpage>551</lpage></element-citation></ref><ref id="CR78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morand</surname><given-names>S</given-names></name><name><surname>McIntyre</surname><given-names>KM</given-names></name><name><surname>Baylis</surname><given-names>M</given-names></name></person-group><article-title>Domesticated animals and human infectious diseases of zoonotic origins: domestication time matters</article-title><source>Infect Genet Evol</source><year>2014</year><volume>24</volume><fpage>76</fpage><lpage>81</lpage><?supplied-pmid 24642136?><pub-id pub-id-type="pmid">24642136</pub-id></element-citation></ref><ref id="CR79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoberg</surname><given-names>EP</given-names></name><name><surname>Alkire</surname><given-names>NL</given-names></name><name><surname>de Queiroz</surname><given-names>A</given-names></name><name><surname>Jones</surname><given-names>A</given-names></name></person-group><article-title>Out of Africa: origins of the Taenia tapeworms in humans</article-title><source>Proc Biol Sci</source><year>2001</year><volume>268</volume><fpage>781</fpage><lpage>787</lpage><?supplied-pmid 11345321?><pub-id pub-id-type="pmid">11345321</pub-id></element-citation></ref><ref id="CR80"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Childs</surname><given-names>JE</given-names></name><name><surname>Gordon</surname><given-names>ER</given-names></name></person-group><article-title>Surveillance and control of zoonotic agents prior to disease detection in humans</article-title><source>Mt Sinai J Med</source><year>2009</year><volume>76</volume><fpage>421</fpage><lpage>428</lpage><?supplied-pmid 19787654?><pub-id pub-id-type="pmid">19787654</pub-id></element-citation></ref><ref id="CR81"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angeletti</surname><given-names>S</given-names></name><name><surname>Ceccarelli</surname><given-names>G</given-names></name><name><surname>Vita</surname><given-names>S</given-names></name><name><surname>Dicuonzo</surname><given-names>G</given-names></name><name><surname>Lopalco</surname><given-names>M</given-names></name><name><surname>Dedej</surname><given-names>E</given-names></name><etal/></person-group><article-title>Unusual microorganisms and antimicrobial resistances in a group of Syrian migrants: sentinel surveillance data from an asylum seekers centre in Italy</article-title><source>Travel Med Infect Dis</source><year>2016</year><volume>14</volume><fpage>115</fpage><lpage>122</lpage><?supplied-pmid 26987764?><pub-id pub-id-type="pmid">26987764</pub-id></element-citation></ref><ref id="CR82"><label>82.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kilonzo</surname><given-names>C</given-names></name><name><surname>Stopka</surname><given-names>TJ</given-names></name><name><surname>Chomel</surname><given-names>B</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Singh</surname><given-names>SK</given-names></name></person-group><article-title>Illegal animal and (bush) meat trade associated risk of spread of viral infections</article-title><source>Viral infections and global change chapter: 10 Illegal animal and (bush) meat trade associated risk of spread of viral infection</source><year>2013</year><publisher-loc>Hoboken</publisher-loc><publisher-name>Wiley</publisher-name><fpage>179</fpage><lpage>194</lpage></element-citation></ref><ref id="CR83"><label>83.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Institute of Medicine</collab></person-group><person-group person-group-type="editor"><name><surname>Harrison</surname><given-names>PF</given-names></name><name><surname>Lederberg</surname><given-names>J</given-names></name></person-group><article-title>Forum on emerging infections</article-title><source>Antimicrobial resistance: issues and options</source><year>1998</year><publisher-loc>Washington, DC</publisher-loc><publisher-name>The National Academies Press</publisher-name><fpage>128</fpage></element-citation></ref><ref id="CR84"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boucher</surname><given-names>HW</given-names></name><name><surname>Talbot</surname><given-names>GH</given-names></name><name><surname>Bradley</surname><given-names>JS</given-names></name><name><surname>Edwards</surname><given-names>JE</given-names></name><name><surname>Gilbert</surname><given-names>D</given-names></name><name><surname>Rice</surname><given-names>LB</given-names></name><etal/></person-group><article-title>Bad bugs, no drugs: no ESKAPE! an update from the infectious diseases society of America</article-title><source>Clin Infect Dis</source><year>2009</year><volume>48</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">19035777</pub-id></element-citation></ref><ref id="CR85"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spellberg</surname><given-names>B</given-names></name><name><surname>Guidos</surname><given-names>R</given-names></name><name><surname>Gilbert</surname><given-names>D</given-names></name><name><surname>Bradley</surname><given-names>J</given-names></name><name><surname>Boucher</surname><given-names>HW</given-names></name><name><surname>Scheld</surname><given-names>WM</given-names></name><etal/></person-group><article-title>The epidemic of antibiotic-resistant infections: a call to action for the medical community from the infectious diseases society of America</article-title><source>Clin Infect Dis</source><year>2008</year><volume>46</volume><fpage>155</fpage><lpage>164</lpage><?supplied-pmid 18171244?><pub-id pub-id-type="pmid">18171244</pub-id></element-citation></ref><ref id="CR86"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taubes</surname><given-names>G</given-names></name></person-group><article-title>The bacteria fight back</article-title><source>Science.</source><year>2008</year><volume>321</volume><fpage>356</fpage><lpage>361</lpage><?supplied-pmid 18635788?><pub-id pub-id-type="pmid">18635788</pub-id></element-citation></ref><ref id="CR87"><label>87.</label><mixed-citation publication-type="other">Review on Antimicrobial Resistance. Tackling drug-resistant infections globally: final report and recommendations. Review on Antimicrobial Resistance; 2016.</mixed-citation></ref><ref id="CR88"><label>88.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>United Nations Interagency Coordination Group on Antimicrobial Resistance</collab></person-group><source>AMR framework for action supported by the IACG. Working document</source><year>2017</year><publisher-loc>Geneva</publisher-loc><publisher-name>United Nations Interagency Coordination Group on Antimicrobial Resistance</publisher-name></element-citation></ref><ref id="CR89"><label>89.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>World Bank</collab></person-group><source>Drug-resistant infections: a threat to our economic future (discussion draft)</source><year>2016</year><publisher-loc>Washington, DC</publisher-loc><publisher-name>World Bank</publisher-name></element-citation></ref><ref id="CR90"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Centers for Disease Control and Prevention (CDC)</collab></person-group><article-title>Notes from the field: New Delhi metallo-beta-lactamase-producing <italic>Escherichia coli</italic> associated with endoscopic retrograde cholangiopancreatography - Illinois, 2013</article-title><source>MMWR Morb Mortal Wkly Rep</source><year>2014</year><volume>62</volume><fpage>1051</fpage><pub-id pub-id-type="pmid">24381080</pub-id></element-citation></ref><ref id="CR91"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Centers for Disease Control and Prevention (CDC)</collab></person-group><article-title>Notes from the field: hospital outbreak of carbapenem-resistant Klebsiella pneumoniae producing New Delhi metallo-beta-lactamase--Denver, Colorado, 2012</article-title><source>MMWR Morb Mortal Wkly Rep</source><year>2013</year><volume>62</volume><fpage>108</fpage><pub-id pub-id-type="pmid">23407128</pub-id></element-citation></ref><ref id="CR92"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Centers for Disease Control and Prevention (CDC)</collab></person-group><article-title>Carbapenem-resistant Klebsiella pneumoniae associated with a long-term care facility&#x02014;West Virginia, 2009-2011</article-title><source>MMWR Morb Mortal Wkly Rep</source><year>2011</year><volume>60</volume><fpage>1418</fpage><lpage>1420</lpage><pub-id pub-id-type="pmid">22012114</pub-id></element-citation></ref><ref id="CR93"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doi</surname><given-names>Y</given-names></name><name><surname>Paterson</surname><given-names>DL</given-names></name></person-group><article-title>Carbapenemase-producing Enterobacteriaceae</article-title><source>Semin Respir Crit Care Med</source><year>2015</year><volume>36</volume><fpage>74</fpage><lpage>84</lpage><?supplied-pmid 25643272?><pub-id pub-id-type="pmid">25643272</pub-id></element-citation></ref><ref id="CR94"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGann</surname><given-names>P</given-names></name><name><surname>Hang</surname><given-names>J</given-names></name><name><surname>Clifford</surname><given-names>RJ</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Kwak</surname><given-names>YI</given-names></name><name><surname>Kuschner</surname><given-names>RA</given-names></name><etal/></person-group><article-title>Complete sequence of a novel 178-kilobase plasmid carrying bla(NDM-1) in a <italic>Providencia stuartii</italic> strain isolated in Afghanistan</article-title><source>Antimicrob Agents Chemother</source><year>2012</year><volume>56</volume><fpage>1673</fpage><lpage>1679</lpage><?supplied-pmid 22290972?><pub-id pub-id-type="pmid">22290972</pub-id></element-citation></ref><ref id="CR95"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ochman</surname><given-names>H</given-names></name><name><surname>Moran</surname><given-names>NA</given-names></name></person-group><article-title>Genes lost and genes found: evolution of bacterial pathogenesis and symbiosis</article-title><source>Science.</source><year>2001</year><volume>292</volume><fpage>1096</fpage><lpage>1099</lpage><?supplied-pmid 11352062?><pub-id pub-id-type="pmid">11352062</pub-id></element-citation></ref><ref id="CR96"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Usluer</surname><given-names>G</given-names></name><name><surname>Ozgunes</surname><given-names>I</given-names></name><name><surname>Leblebicioglu</surname><given-names>H</given-names></name></person-group><article-title>A multicenter point-prevalence study: antimicrobial prescription frequencies in hospitalized patients in Turkey</article-title><source>Ann Clin Microbiol Antimicrob</source><year>2005</year><volume>4</volume><fpage>16</fpage><?supplied-pmid 16202139?><pub-id pub-id-type="pmid">16202139</pub-id></element-citation></ref><ref id="CR97"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saleh</surname><given-names>N</given-names></name><name><surname>Awada</surname><given-names>S</given-names></name><name><surname>Awwad</surname><given-names>R</given-names></name><name><surname>Jibai</surname><given-names>S</given-names></name><name><surname>Arfoul</surname><given-names>C</given-names></name><name><surname>Zaiter</surname><given-names>L</given-names></name><etal/></person-group><article-title>Evaluation of antibiotic prescription in the Lebanese community: a pilot study</article-title><source>Infect Ecol Epidemiol</source><year>2015</year><volume>5</volume><fpage>27094</fpage><?supplied-pmid 26112266?><pub-id pub-id-type="pmid">26112266</pub-id></element-citation></ref><ref id="CR98"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neu</surname><given-names>HC</given-names></name></person-group><article-title>The crisis in antibiotic resistance</article-title><source>Science.</source><year>1992</year><volume>257</volume><fpage>1064</fpage><lpage>1073</lpage><?supplied-pmid 1509257?><pub-id pub-id-type="pmid">1509257</pub-id></element-citation></ref><ref id="CR99"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>ML</given-names></name></person-group><article-title>Changing patterns of infectious disease</article-title><source>Nature.</source><year>2000</year><volume>406</volume><fpage>762</fpage><lpage>767</lpage><?supplied-pmid 10963605?><pub-id pub-id-type="pmid">10963605</pub-id></element-citation></ref><ref id="CR100"><label>100.</label><mixed-citation publication-type="other">European Centre for Disease Prevention Control. Antimicrobial resistance surveillance in Europe 2015. Annual report of the European antimicrobial resistance surveillance network (EARS-Net). Stockholm: ECDC. p. 2015.</mixed-citation></ref><ref id="CR101"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakou</surname><given-names>A</given-names></name><name><surname>Woodhead</surname><given-names>M</given-names></name><name><surname>Torres</surname><given-names>A</given-names></name></person-group><article-title>MRSA as a cause of community-acquired pneumonia</article-title><source>Eur Respir J</source><year>2009</year><volume>34</volume><fpage>1013</fpage><lpage>1014</lpage><?supplied-pmid 19880614?><pub-id pub-id-type="pmid">19880614</pub-id></element-citation></ref><ref id="CR102"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vardakas</surname><given-names>KZ</given-names></name><name><surname>Matthaiou</surname><given-names>DK</given-names></name><name><surname>Falagas</surname><given-names>ME</given-names></name></person-group><article-title>Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia</article-title><source>Eur Respir J</source><year>2009</year><volume>34</volume><fpage>1148</fpage><lpage>1158</lpage><?supplied-pmid 19541719?><pub-id pub-id-type="pmid">19541719</pub-id></element-citation></ref><ref id="CR103"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Livermore</surname><given-names>DM</given-names></name><name><surname>Canton</surname><given-names>R</given-names></name><name><surname>Gniadkowski</surname><given-names>M</given-names></name><name><surname>Nordmann</surname><given-names>P</given-names></name><name><surname>Rossolini</surname><given-names>GM</given-names></name><name><surname>Arlet</surname><given-names>G</given-names></name><etal/></person-group><article-title>CTX-M: changing the face of ESBLs in Europe</article-title><source>J Antimicrob Chemother</source><year>2007</year><volume>59</volume><fpage>165</fpage><lpage>174</lpage><?supplied-pmid 17158117?><pub-id pub-id-type="pmid">17158117</pub-id></element-citation></ref><ref id="CR104"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Queenan</surname><given-names>AM</given-names></name><name><surname>Bush</surname><given-names>K</given-names></name></person-group><article-title>Carbapenemases: the versatile beta-lactamases</article-title><source>Clin Microbiol Rev</source><year>2007</year><volume>20</volume><fpage>440</fpage><lpage>458</lpage><?supplied-pmid 17630334?><pub-id pub-id-type="pmid">17630334</pub-id></element-citation></ref><ref id="CR105"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peleg</surname><given-names>AY</given-names></name><name><surname>Seifert</surname><given-names>H</given-names></name><name><surname>Paterson</surname><given-names>DL</given-names></name></person-group><article-title>Acinetobacter baumannii: emergence of a successful pathogen</article-title><source>Clin Microbiol Rev</source><year>2008</year><volume>21</volume><fpage>538</fpage><lpage>582</lpage><?supplied-pmid 18625687?><pub-id pub-id-type="pmid">18625687</pub-id></element-citation></ref><ref id="CR106"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basu</surname><given-names>A</given-names></name><name><surname>Garg</surname><given-names>P</given-names></name><name><surname>Datta</surname><given-names>S</given-names></name><name><surname>Chakraborty</surname><given-names>S</given-names></name><name><surname>Bhattacharya</surname><given-names>T</given-names></name><name><surname>Khan</surname><given-names>A</given-names></name><etal/></person-group><article-title><italic>Vibrio cholerae</italic> O139 in Calcutta, 1992-1998: incidence, antibiograms, and genotypes</article-title><source>Emerg Infect Dis</source><year>2000</year><volume>6</volume><fpage>139</fpage><lpage>147</lpage><?supplied-pmid 10756147?><pub-id pub-id-type="pmid">10756147</pub-id></element-citation></ref><ref id="CR107"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faruque</surname><given-names>SM</given-names></name><name><surname>Abdul Alim</surname><given-names>AR</given-names></name><name><surname>Rahman</surname><given-names>MM</given-names></name><name><surname>Siddique</surname><given-names>AK</given-names></name><name><surname>Sack</surname><given-names>RB</given-names></name><name><surname>Albert</surname><given-names>MJ</given-names></name></person-group><article-title>Clonal relationships among classical <italic>Vibrio cholerae</italic> O1 strains isolated between 1961 and 1992 in Bangladesh</article-title><source>J Clin Microbiol</source><year>1993</year><volume>31</volume><fpage>2513</fpage><lpage>2516</lpage><?supplied-pmid 7691878?><pub-id pub-id-type="pmid">7691878</pub-id></element-citation></ref><ref id="CR108"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukhopadhyay</surname><given-names>AK</given-names></name><name><surname>Garg</surname><given-names>S</given-names></name><name><surname>Mitra</surname><given-names>R</given-names></name><name><surname>Basu</surname><given-names>A</given-names></name><name><surname>Rajendran</surname><given-names>K</given-names></name><name><surname>Dutta</surname><given-names>D</given-names></name><etal/></person-group><article-title>Temporal shifts in traits of <italic>Vibrio cholerae</italic> strains isolated from hospitalized patients in Calcutta: a 3-year (1993 to 1995) analysis</article-title><source>J Clin Microbiol</source><year>1996</year><volume>34</volume><fpage>2537</fpage><lpage>2543</lpage><?supplied-pmid 8880516?><pub-id pub-id-type="pmid">8880516</pub-id></element-citation></ref><ref id="CR109"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>C</given-names></name><name><surname>Maiti</surname><given-names>S</given-names></name><name><surname>Mukhopadhyay</surname><given-names>AK</given-names></name><name><surname>Basu</surname><given-names>A</given-names></name><name><surname>Basu</surname><given-names>I</given-names></name><name><surname>Nair</surname><given-names>GB</given-names></name><etal/></person-group><article-title>Unique organization of the CTX genetic element in <italic>Vibrio cholerae</italic> O139 strains which reemerged in Calcutta, India, in September 1996</article-title><source>J Clin Microbiol</source><year>1997</year><volume>35</volume><fpage>3348</fpage><lpage>3350</lpage><?supplied-pmid 9399556?><pub-id pub-id-type="pmid">9399556</pub-id></element-citation></ref><ref id="CR110"><label>110.</label><mixed-citation publication-type="other">European Centre for Disease PC. Tuberculosis surveillance and monitoring in Europe 2012. 2020. <ext-link ext-link-type="uri" xlink:href="https://www.ecdc.europa.eu/en/publications-data/tuberculosis-surveillance-and-monitoring-europe-2012">https://www.ecdc.europa.eu/en/publications-data/tuberculosis-surveillance-and-monitoring-europe-2012</ext-link>. Accessed 26 Jul 2020.</mixed-citation></ref><ref id="CR111"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loddenkemper</surname><given-names>R</given-names></name><name><surname>Sotgiu</surname><given-names>G</given-names></name><name><surname>Mitnick</surname><given-names>CD</given-names></name></person-group><article-title>Cost of tuberculosis in the era of multidrug resistance: will it become unaffordable?</article-title><source>Eur Respir J</source><year>2012</year><volume>40</volume><fpage>9</fpage><lpage>11</lpage><?supplied-pmid 22753833?><pub-id pub-id-type="pmid">22753833</pub-id></element-citation></ref><ref id="CR112"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vidaver</surname><given-names>AK</given-names></name></person-group><article-title>Uses of antimicrobials in plant agriculture</article-title><source>Clin Infect Dis</source><year>2002</year><volume>34</volume><fpage>S107</fpage><lpage>S110</lpage><?supplied-pmid 11988880?><pub-id pub-id-type="pmid">11988880</pub-id></element-citation></ref><ref id="CR113"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aarestrup</surname><given-names>F</given-names></name></person-group><article-title>Sustainable farming: get pigs off antibiotics</article-title><source>Nature.</source><year>2012</year><volume>486</volume><fpage>465</fpage><lpage>466</lpage><?supplied-pmid 22739296?><pub-id pub-id-type="pmid">22739296</pub-id></element-citation></ref><ref id="CR114"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Addis</surname><given-names>Z</given-names></name><name><surname>Kebede</surname><given-names>N</given-names></name><name><surname>Worku</surname><given-names>Z</given-names></name><name><surname>Gezahegn</surname><given-names>H</given-names></name><name><surname>Yirsaw</surname><given-names>A</given-names></name><name><surname>Kassa</surname><given-names>T</given-names></name></person-group><article-title>Prevalence and antimicrobial resistance of <italic>Salmonella</italic> isolated from lactating cows and in contact humans in dairy farms of Addis Ababa: a cross sectional study</article-title><source>BMC Infect Dis</source><year>2011</year><volume>11</volume><fpage>222</fpage><?supplied-pmid 21854583?><pub-id pub-id-type="pmid">21854583</pub-id></element-citation></ref><ref id="CR115"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doyle</surname><given-names>ME</given-names></name></person-group><article-title>Multidrug-resistant pathogens in the food supply</article-title><source>Foodborne Pathog Dis</source><year>2015</year><volume>12</volume><fpage>261</fpage><lpage>279</lpage><?supplied-pmid 25621383?><pub-id pub-id-type="pmid">25621383</pub-id></element-citation></ref><ref id="CR116"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fortini</surname><given-names>D</given-names></name><name><surname>Fashae</surname><given-names>K</given-names></name><name><surname>Garcia-Fernandez</surname><given-names>A</given-names></name><name><surname>Villa</surname><given-names>L</given-names></name><name><surname>Carattoli</surname><given-names>A</given-names></name></person-group><article-title>Plasmid-mediated quinolone resistance and beta-lactamases in <italic>Escherichia coli</italic> from healthy animals from Nigeria</article-title><source>J Antimicrob Chemother</source><year>2011</year><volume>66</volume><fpage>1269</fpage><lpage>1272</lpage><?supplied-pmid 21393162?><pub-id pub-id-type="pmid">21393162</pub-id></element-citation></ref><ref id="CR117"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kikuvi</surname><given-names>GM</given-names></name><name><surname>Ombui</surname><given-names>JN</given-names></name><name><surname>Mitema</surname><given-names>ES</given-names></name></person-group><article-title>Serotypes and antimicrobial resistance profiles of Salmonella isolates from pigs at slaughter in Kenya</article-title><source>J Infect Dev Ctries</source><year>2010</year><volume>4</volume><fpage>243</fpage><lpage>248</lpage><?supplied-pmid 20440063?><pub-id pub-id-type="pmid">20440063</pub-id></element-citation></ref><ref id="CR118"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mezali</surname><given-names>L</given-names></name><name><surname>Hamdi</surname><given-names>TM</given-names></name></person-group><article-title>Prevalence and antimicrobial resistance of Salmonella isolated from meat and meat products in Algiers (Algeria)</article-title><source>Foodborne Pathog Dis</source><year>2012</year><volume>9</volume><fpage>522</fpage><lpage>529</lpage><?supplied-pmid 22571639?><pub-id pub-id-type="pmid">22571639</pub-id></element-citation></ref><ref id="CR119"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitema</surname><given-names>ES</given-names></name><name><surname>Kikuvi</surname><given-names>GM</given-names></name><name><surname>Wegener</surname><given-names>HC</given-names></name><name><surname>Stohr</surname><given-names>K</given-names></name></person-group><article-title>An assessment of antimicrobial consumption in food producing animals in Kenya</article-title><source>J Vet Pharmacol Ther</source><year>2001</year><volume>24</volume><fpage>385</fpage><lpage>390</lpage><?supplied-pmid 11903868?><pub-id pub-id-type="pmid">11903868</pub-id></element-citation></ref><ref id="CR120"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simango</surname><given-names>C</given-names></name><name><surname>Rukure</surname><given-names>G</given-names></name></person-group><article-title>Potential sources of <italic>Campylobacter</italic> species in the homes of farmworkers in Zimbabwe</article-title><source>J Trop Med Hyg</source><year>1991</year><volume>94</volume><fpage>388</fpage><lpage>392</lpage><?supplied-pmid 1758009?><pub-id pub-id-type="pmid">1758009</pub-id></element-citation></ref><ref id="CR121"><label>121.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Wall</surname><given-names>B</given-names></name><name><surname>Mateus</surname><given-names>A</given-names></name><name><surname>Marshall</surname><given-names>L</given-names></name><name><surname>Pfeiffer</surname><given-names>D</given-names></name><name><surname>Lubroth</surname><given-names>J</given-names></name><name><surname>Ormel</surname><given-names>H</given-names></name><etal/></person-group><source>Drivers, dynamics and epidemiology of antimicrobial resistance in animal production</source><year>2016</year><publisher-loc>Rome</publisher-loc><publisher-name>Food and Agriculture Organization</publisher-name></element-citation></ref><ref id="CR122"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Witte</surname><given-names>W</given-names></name></person-group><article-title>Medical consequences of antibiotic use in agriculture</article-title><source>Science.</source><year>1998</year><volume>279</volume><fpage>996</fpage><lpage>997</lpage><?supplied-pmid 9490487?><pub-id pub-id-type="pmid">9490487</pub-id></element-citation></ref><ref id="CR123"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Byarugaba</surname><given-names>DK</given-names></name></person-group><article-title>A view on antimicrobial resistance in developing countries and responsible risk factors</article-title><source>Int J Antimicrob Agents</source><year>2004</year><volume>24</volume><fpage>105</fpage><lpage>110</lpage><?supplied-pmid 15288307?><pub-id pub-id-type="pmid">15288307</pub-id></element-citation></ref><ref id="CR124"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laxminarayan</surname><given-names>R</given-names></name><name><surname>Duse</surname><given-names>A</given-names></name><name><surname>Wattal</surname><given-names>C</given-names></name><name><surname>Zaidi</surname><given-names>AK</given-names></name><name><surname>Wertheim</surname><given-names>HF</given-names></name><name><surname>Sumpradit</surname><given-names>N</given-names></name><etal/></person-group><article-title>Antibiotic resistance-the need for global solutions</article-title><source>Lancet Infect Dis</source><year>2013</year><volume>13</volume><fpage>1057</fpage><lpage>1098</lpage><?supplied-pmid 24252483?><pub-id pub-id-type="pmid">24252483</pub-id></element-citation></ref><ref id="CR125"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okeke</surname><given-names>IN</given-names></name><name><surname>Klugman</surname><given-names>KP</given-names></name><name><surname>Bhutta</surname><given-names>ZA</given-names></name><name><surname>Duse</surname><given-names>AG</given-names></name><name><surname>Jenkins</surname><given-names>P</given-names></name><name><surname>O'Brien</surname><given-names>TF</given-names></name><etal/></person-group><article-title>Antimicrobial resistance in developing countries. Part II: strategies for containment</article-title><source>Lancet Infect Dis</source><year>2005</year><volume>5</volume><fpage>568</fpage><lpage>580</lpage><?supplied-pmid 16122680?><pub-id pub-id-type="pmid">16122680</pub-id></element-citation></ref><ref id="CR126"><label>126.</label><mixed-citation publication-type="other">World Health Organization. Assessing non-prescription and inappropriate use of antibiotics: report on survey. 2019. <ext-link ext-link-type="uri" xlink:href="https://apps.who.int/iris/bitstream/handle/10665/312306/9789289054089-eng.pdf?sequence=1&#x00026;isAllowed=y">https://apps.who.int/iris/bitstream/handle/10665/312306/9789289054089-eng.pdf?sequence=1&#x00026;isAllowed=y</ext-link>. Accessed 26 Jul 2020.</mixed-citation></ref><ref id="CR127"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Alliance for the Prudent Use of Antibiotics</collab></person-group><article-title>Executive summary: select findings, conclusions, and policy recommendations</article-title><source>Clin Infect Dis</source><year>2005</year><volume>41</volume><fpage>S224</fpage><lpage>S227</lpage><pub-id pub-id-type="pmid">16032556</pub-id></element-citation></ref><ref id="CR128"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goossens</surname><given-names>H</given-names></name><name><surname>Ferech</surname><given-names>M</given-names></name><name><surname>Vander Stichele</surname><given-names>R</given-names></name><name><surname>Elseviers</surname><given-names>M</given-names></name></person-group><article-title>Outpatient antibiotic use in Europe and association with resistance: a cross-national database study</article-title><source>Lancet.</source><year>2005</year><volume>365</volume><fpage>579</fpage><lpage>587</lpage><?supplied-pmid 15708101?><pub-id pub-id-type="pmid">15708101</pub-id></element-citation></ref><ref id="CR129"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kunin</surname><given-names>CM</given-names></name></person-group><article-title>Resistance to antimicrobial drugs&#x02014;a world wide calamity</article-title><source>Ann Intern Med</source><year>1993</year><volume>118</volume><fpage>557</fpage><lpage>561</lpage><?supplied-pmid 8442626?><pub-id pub-id-type="pmid">8442626</pub-id></element-citation></ref><ref id="CR130"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okeke</surname><given-names>IN</given-names></name><name><surname>Lamikanra</surname><given-names>A</given-names></name><name><surname>Edelman</surname><given-names>R</given-names></name></person-group><article-title>Socioeconomic and behavioral factors leading to acquired bacterial resistance to antibiotics in developing countries</article-title><source>Emerg Infect Dis</source><year>1999</year><volume>5</volume><fpage>18</fpage><lpage>27</lpage><?supplied-pmid 10081668?><pub-id pub-id-type="pmid">10081668</pub-id></element-citation></ref><ref id="CR131"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okeke</surname><given-names>IN</given-names></name><name><surname>Laxminarayan</surname><given-names>R</given-names></name><name><surname>Bhutta</surname><given-names>ZA</given-names></name><name><surname>Duse</surname><given-names>AG</given-names></name><name><surname>Jenkins</surname><given-names>P</given-names></name><name><surname>O'Brien</surname><given-names>TF</given-names></name><etal/></person-group><article-title>Antimicrobial resistance in developing countries. Part I: recent trends and current status</article-title><source>Lancet Infect Dis</source><year>2005</year><volume>5</volume><fpage>481</fpage><lpage>493</lpage><?supplied-pmid 16048717?><pub-id pub-id-type="pmid">16048717</pub-id></element-citation></ref><ref id="CR132"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fridkin</surname><given-names>S</given-names></name><name><surname>Baggs</surname><given-names>J</given-names></name><name><surname>Fagan</surname><given-names>R</given-names></name><name><surname>Magill</surname><given-names>S</given-names></name><name><surname>Pollack</surname><given-names>LA</given-names></name><name><surname>Malpiedi</surname><given-names>P</given-names></name><etal/></person-group><article-title>Vital signs: improving antibiotic use among hospitalized patients</article-title><source>MMWR Morb Mortal Wkly Rep</source><year>2014</year><volume>63</volume><fpage>194</fpage><lpage>200</lpage><?supplied-pmid 24598596?><pub-id pub-id-type="pmid">24598596</pub-id></element-citation></ref><ref id="CR133"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marston</surname><given-names>HD</given-names></name><name><surname>Dixon</surname><given-names>DM</given-names></name><name><surname>Knisely</surname><given-names>JM</given-names></name><name><surname>Palmore</surname><given-names>TN</given-names></name><name><surname>Fauci</surname><given-names>AS</given-names></name></person-group><article-title>Antimicrobial resistance</article-title><source>JAMA.</source><year>2016</year><volume>316</volume><fpage>1193</fpage><lpage>1204</lpage><?supplied-pmid 27654605?><pub-id pub-id-type="pmid">27654605</pub-id></element-citation></ref><ref id="CR134"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>AV</given-names></name></person-group><article-title>The immunogenetics of human infectious diseases</article-title><source>Annu Rev Immunol</source><year>1998</year><volume>16</volume><fpage>593</fpage><lpage>617</lpage><?supplied-pmid 9597143?><pub-id pub-id-type="pmid">9597143</pub-id></element-citation></ref><ref id="CR135"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lederberg</surname><given-names>JJBS</given-names></name></person-group><article-title>Haldane (1949) on infectious disease and evolution</article-title><source>Genetics.</source><year>1999</year><volume>153</volume><fpage>1</fpage><lpage>3</lpage><?supplied-pmid 10471694?><pub-id pub-id-type="pmid">10471694</pub-id></element-citation></ref><ref id="CR136"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weatherall</surname><given-names>DJ</given-names></name></person-group><article-title>The genetics of common diseases: the implications of population variability</article-title><source>CIBA Found Symp</source><year>1996</year><volume>197</volume><fpage>300</fpage><lpage>308</lpage><?supplied-pmid 8827380?><pub-id pub-id-type="pmid">8827380</pub-id></element-citation></ref><ref id="CR137"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weatherall</surname><given-names>DJ</given-names></name></person-group><article-title>Host genetics and infectious disease</article-title><source>Parasitology.</source><year>1996</year><volume>112</volume><fpage>S23</fpage><lpage>S29</lpage><?supplied-pmid 8684833?><pub-id pub-id-type="pmid">8684833</pub-id></element-citation></ref><ref id="CR138"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rice</surname><given-names>AL</given-names></name><name><surname>Sacco</surname><given-names>L</given-names></name><name><surname>Hyder</surname><given-names>A</given-names></name><name><surname>Black</surname><given-names>RE</given-names></name></person-group><article-title>Malnutrition as an underlying cause of childhood deaths associated with infectious diseases in developing countries</article-title><source>Bull World Health Organ</source><year>2000</year><volume>78</volume><fpage>1207</fpage><lpage>1221</lpage><?supplied-pmid 11100616?><pub-id pub-id-type="pmid">11100616</pub-id></element-citation></ref><ref id="CR139"><label>139.</label><mixed-citation publication-type="other">World Health Organization. Fifty-third world health assembly, provisional agenda item 12.4, A53/7. Infant and young child nutrition, Report by the director-general. 2000. <ext-link ext-link-type="uri" xlink:href="https://apps.who.int/gb/archive/pdf_files/WHA53/ea7.pdf">https://apps.who.int/gb/archive/pdf_files/WHA53/ea7.pdf</ext-link>. Accessed 26 Jul 2020.</mixed-citation></ref><ref id="CR140"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dixon</surname><given-names>DM</given-names></name><name><surname>McNeil</surname><given-names>MM</given-names></name><name><surname>Cohen</surname><given-names>ML</given-names></name><name><surname>Gellin</surname><given-names>BG</given-names></name><name><surname>La Montagne</surname><given-names>JR</given-names></name></person-group><article-title>Fungal infections: a growing threat</article-title><source>Public Health Rep</source><year>1996</year><volume>111</volume><fpage>226</fpage><lpage>235</lpage><?supplied-pmid 8643813?><pub-id pub-id-type="pmid">8643813</pub-id></element-citation></ref><ref id="CR141"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>JG</given-names><suffix>Jr</suffix></name><name><surname>Potter</surname><given-names>M</given-names></name></person-group><article-title>Emergence of new pathogens as a function of changes in host susceptibility</article-title><source>Emerg Infect Dis</source><year>1997</year><volume>3</volume><fpage>435</fpage><lpage>441</lpage><?supplied-pmid 9368786?><pub-id pub-id-type="pmid">9368786</pub-id></element-citation></ref><ref id="CR142"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>QL</given-names></name><name><surname>Tang</surname><given-names>SY</given-names></name><name><surname>Xiao</surname><given-names>YN</given-names></name></person-group><article-title>Impact of individual behaviour change on the spread of emerging infectious diseases</article-title><source>Stat Med</source><year>2018</year><volume>37</volume><fpage>948</fpage><lpage>969</lpage><?supplied-pmid 29193194?><pub-id pub-id-type="pmid">29193194</pub-id></element-citation></ref><ref id="CR143"><label>143.</label><mixed-citation publication-type="other">Rockville. Improving cultural competence. 2020. <ext-link ext-link-type="uri" xlink:href="https://store.samhsa.gov/sites/default/files/d7/priv/sma14-4849.pdf">https://store.samhsa.gov/sites/default/files/d7/priv/sma14-4849.pdf</ext-link>. Accessed 26 Jul 2020.</mixed-citation></ref><ref id="CR144"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mawar</surname><given-names>N</given-names></name><name><surname>Saha</surname><given-names>S</given-names></name><name><surname>Pandit</surname><given-names>A</given-names></name><name><surname>Mahajan</surname><given-names>U</given-names></name></person-group><article-title>The third phase of HIV pandemic: social consequences of HIV/AIDS stigma &#x00026; discrimination &#x00026; future needs</article-title><source>Indian J Med Res</source><year>2005</year><volume>122</volume><fpage>471</fpage><lpage>484</lpage><?supplied-pmid 16517997?><pub-id pub-id-type="pmid">16517997</pub-id></element-citation></ref><ref id="CR145"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vinck</surname><given-names>P</given-names></name><name><surname>Pham</surname><given-names>PN</given-names></name><name><surname>Bindu</surname><given-names>KK</given-names></name><name><surname>Bedford</surname><given-names>J</given-names></name><name><surname>Nilles</surname><given-names>EJ</given-names></name></person-group><article-title>Institutional trust and misinformation in the response to the 2018&#x02013;19 Ebola outbreak in North Kivu, DR Congo: a population-based survey</article-title><source>Lancet Infect Dis</source><year>2019</year><volume>19</volume><fpage>529</fpage><lpage>536</lpage><?supplied-pmid 30928435?><pub-id pub-id-type="pmid">30928435</pub-id></element-citation></ref><ref id="CR146"><label>146.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>W</given-names></name><name><surname>Couzin</surname><given-names>O</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Detels</surname><given-names>R</given-names></name><name><surname>Bulterys</surname><given-names>M</given-names></name><name><surname>McGoogan</surname><given-names>JM</given-names></name></person-group><article-title>HIV-related stigma and discrimination in China</article-title><source>HIV/AIDS in China: epidemiology, prevention and treatment</source><year>2020</year><publisher-loc>Singapore</publisher-loc><publisher-name>Springer</publisher-name><fpage>515</fpage><lpage>541</lpage></element-citation></ref><ref id="CR147"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agnieszka</surname><given-names>R</given-names></name><name><surname>Jan</surname><given-names>OA</given-names></name></person-group><article-title>Conflicts of human behavior in organizations and the influence of human factor on innovation</article-title><source>IOSR J Bus Manag</source><year>2016</year><volume>18</volume><fpage>35</fpage><lpage>41</lpage></element-citation></ref><ref id="CR148"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bloom</surname><given-names>DE</given-names></name><name><surname>Cadarette</surname><given-names>D</given-names></name></person-group><article-title>Infectious disease threats in the twenty-first century: strengthening the global response</article-title><source>Front Immunol</source><year>2019</year><volume>10</volume><fpage>549</fpage><?supplied-pmid 30984169?><pub-id pub-id-type="pmid">30984169</pub-id></element-citation></ref><ref id="CR149"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gayer</surname><given-names>M</given-names></name><name><surname>Legros</surname><given-names>D</given-names></name><name><surname>Formenty</surname><given-names>P</given-names></name><name><surname>Connolly</surname><given-names>MA</given-names></name></person-group><article-title>Conflict and emerging infectious diseases</article-title><source>Emerg Infect Dis</source><year>2007</year><volume>13</volume><fpage>1625</fpage><lpage>1631</lpage><?supplied-pmid 18217543?><pub-id pub-id-type="pmid">18217543</pub-id></element-citation></ref><ref id="CR150"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharara</surname><given-names>SL</given-names></name><name><surname>Kanj</surname><given-names>SS</given-names></name></person-group><article-title>War and infectious diseases: challenges of the Syrian civil war</article-title><source>PLoS Pathog</source><year>2014</year><volume>10</volume><fpage>e1004438</fpage><?supplied-pmid 25393545?><pub-id pub-id-type="pmid">25393545</pub-id></element-citation></ref><ref id="CR151"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abbas</surname><given-names>M</given-names></name><name><surname>Aloudat</surname><given-names>T</given-names></name><name><surname>Bartolomei</surname><given-names>J</given-names></name><name><surname>Carballo</surname><given-names>M</given-names></name><name><surname>Durieux-Paillard</surname><given-names>S</given-names></name><name><surname>Gabus</surname><given-names>L</given-names></name><etal/></person-group><article-title>Migrant and refugee populations: a public health and policy perspective on a continuing global crisis</article-title><source>Antimicrob Resist Infect Control</source><year>2018</year><volume>7</volume><fpage>113</fpage><?supplied-pmid 30250735?><pub-id pub-id-type="pmid">30250735</pub-id></element-citation></ref><ref id="CR152"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heywood</surname><given-names>AE</given-names></name><name><surname>Castelli</surname><given-names>F</given-names></name><name><surname>Greenaway</surname><given-names>C</given-names></name></person-group><article-title>Migration health: highlights from inaugural international society of travel medicine (ISTM) conference on migration health</article-title><source>Curr Infect Dis Rep</source><year>2019</year><volume>21</volume><fpage>48</fpage><?supplied-pmid 31734735?><pub-id pub-id-type="pmid">31734735</pub-id></element-citation></ref><ref id="CR153"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seedat</surname><given-names>F</given-names></name><name><surname>Hargreaves</surname><given-names>S</given-names></name><name><surname>Nellums</surname><given-names>LB</given-names></name><name><surname>Ouyang</surname><given-names>J</given-names></name><name><surname>Brown</surname><given-names>M</given-names></name><name><surname>Friedland</surname><given-names>JS</given-names></name></person-group><article-title>How effective are approaches to migrant screening for infectious diseases in Europe? A systematic review</article-title><source>Lancet Infect Dis</source><year>2018</year><volume>18</volume><fpage>NIMe259</fpage><lpage>NIMe271</lpage></element-citation></ref><ref id="CR154"><label>154.</label><mixed-citation publication-type="other">UNHCR. Figures at a glance. 2020. <ext-link ext-link-type="uri" xlink:href="http://www.unhcr.org/figures-at-a-glance.html">http://www.unhcr.org/figures-at-a-glance.html</ext-link>. Accessed 26 Jul 2020.</mixed-citation></ref><ref id="CR155"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nimer</surname><given-names>NA</given-names></name></person-group><article-title>A review on emerging and reemerging of infectious diseases in Jordan: the aftermath of the Syrian crises</article-title><source>Can J Infect Dis Med Microbiol</source><year>2018</year><volume>2018</volume><fpage>8679174</fpage><?supplied-pmid 29977415?><pub-id pub-id-type="pmid">29977415</pub-id></element-citation></ref><ref id="CR156"><label>156.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozaras</surname><given-names>R</given-names></name><name><surname>Leblebicioglu</surname><given-names>H</given-names></name><name><surname>Sunbul</surname><given-names>M</given-names></name><name><surname>Tabak</surname><given-names>F</given-names></name><name><surname>Balkan</surname><given-names>II</given-names></name><name><surname>Yemisen</surname><given-names>M</given-names></name><etal/></person-group><article-title>The Syrian conflict and infectious diseases</article-title><source>Expert Rev Anti-Infect Ther</source><year>2016</year><volume>14</volume><fpage>547</fpage><lpage>555</lpage><?supplied-pmid 27063349?><pub-id pub-id-type="pmid">27063349</pub-id></element-citation></ref><ref id="CR157"><label>157.</label><mixed-citation publication-type="other">Centers for Disease Control Prevention. Coronavirus disease 2019 (COVID-2019). 2020. <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/cdcresponse/about-COVID-19.html">https://www.cdc.gov/coronavirus/2019-ncov/cdcresponse/about-COVID-19.html</ext-link>. Accessed 1 Sep 2020.</mixed-citation></ref><ref id="CR158"><label>158.</label><mixed-citation publication-type="other">World Health Organization. Naming the coronavirus disease (COVID-19) and the virus that causes it. 2020. <ext-link ext-link-type="uri" xlink:href="https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it">https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it</ext-link>. Accessed 17 Aug 2020.</mixed-citation></ref><ref id="CR159"><label>159.</label><mixed-citation publication-type="other">Gorbalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA, et al. Severe acute respiratory syndrome-related coronavirus: the species and its viruses&#x02014;a statement of the Coronavirus Study Group. bioRxiv. 2020. 10.1101/2020.02.07.937862.</mixed-citation></ref><ref id="CR160"><label>160.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>H</given-names></name><name><surname>Stratton</surname><given-names>CW</given-names></name><name><surname>Tang</surname><given-names>YW</given-names></name></person-group><article-title>Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle</article-title><source>J Med Virol</source><year>2020</year><volume>92</volume><fpage>401</fpage><lpage>402</lpage><?supplied-pmid 31950516?><pub-id pub-id-type="pmid">31950516</pub-id></element-citation></ref><ref id="CR161"><label>161.</label><mixed-citation publication-type="other">World Health Organization. WHO director-general's remarks at the media briefing on 2019-nCoV on 11 February 2020. 2020. <ext-link ext-link-type="uri" xlink:href="https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020">https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020</ext-link>. Accessed 26 Jul 2020.</mixed-citation></ref><ref id="CR162"><label>162.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Novel Coronavirus Pneumonia Emergency Response Epidemiology Team</collab></person-group><article-title>The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)&#x02014;China, 2020</article-title><source>China CDC Wkly</source><year>2020</year><volume>2</volume><fpage>113</fpage><lpage>122</lpage></element-citation></ref><ref id="CR163"><label>163.</label><mixed-citation publication-type="other">World Health Organization. WHO Coronavirus disease (COVID-19) dashboard. 2020. <ext-link ext-link-type="uri" xlink:href="https://covid19.who.int/">https://covid19.who.int/</ext-link>. Accessed 26 Jul 2020.</mixed-citation></ref><ref id="CR164"><label>164.</label><mixed-citation publication-type="other">World Health Organization. Home care for patients with COVID-19 presenting with mild symptoms and management of their contacts. 2020. <ext-link ext-link-type="uri" xlink:href="https://www.who.int/publications/i/item/home-care-for-patients-with-suspected-novel-coronavirus-(ncov)-infection-presenting-with-mild-symptoms-and-management-of-contacts">https://www.who.int/publications/i/item/home-care-for-patients-with-suspected-novel-coronavirus-(ncov)-infection-presenting-with-mild-symptoms-and-management-of-contacts</ext-link>. Accessed 26 Jul 2020.</mixed-citation></ref><ref id="CR165"><label>165.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hui</surname><given-names>DS</given-names></name><name><surname>Azhar</surname><given-names>EI</given-names></name><name><surname>Kim</surname><given-names>YJ</given-names></name><name><surname>Memish</surname><given-names>ZA</given-names></name><name><surname>Oh</surname><given-names>MD</given-names></name><name><surname>Zumla</surname><given-names>A</given-names></name></person-group><article-title>Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission</article-title><source>Lancet Infect Dis</source><year>2018</year><volume>18</volume><fpage>e217</fpage><lpage>e227</lpage><?supplied-pmid 29680581?><pub-id pub-id-type="pmid">29680581</pub-id></element-citation></ref><ref id="CR166"><label>166.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peiris</surname><given-names>JSM</given-names></name><name><surname>Guan</surname><given-names>Y</given-names></name><name><surname>Yuen</surname><given-names>KY</given-names></name></person-group><article-title>Severe acute respiratory syndrome</article-title><source>Nat Med</source><year>2004</year><volume>10</volume><fpage>S88</fpage><lpage>S97</lpage><?supplied-pmid 15577937?><pub-id pub-id-type="pmid">15577937</pub-id></element-citation></ref><ref id="CR167"><label>167.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riou</surname><given-names>J</given-names></name><name><surname>Althaus</surname><given-names>CL</given-names></name></person-group><article-title>Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020</article-title><source>Euro Surveill</source><year>2020</year><volume>25</volume><fpage>2000058</fpage></element-citation></ref><ref id="CR168"><label>168.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Cheng</surname><given-names>Z</given-names></name><name><surname>Tan</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Zeng</surname><given-names>X</given-names></name><etal/></person-group><article-title>Super-factors associated with transmission of occupational COVID-19 infection among healthcare staff in Wuhan, China</article-title><source>J Hosp Infect</source><year>2020</year><volume>106</volume><fpage>25</fpage><lpage>34</lpage><?supplied-pmid 32574702?><pub-id pub-id-type="pmid">32574702</pub-id></element-citation></ref><ref id="CR169"><label>169.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Zai</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>Q</given-names></name><name><surname>Nie</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Foley</surname><given-names>BT</given-names></name><etal/></person-group><article-title>Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2</article-title><source>J Med Virol</source><year>2020</year><volume>92</volume><fpage>602</fpage><lpage>611</lpage><?supplied-pmid 32104911?><pub-id pub-id-type="pmid">32104911</pub-id></element-citation></ref><ref id="CR170"><label>170.</label><mixed-citation publication-type="other">Liu P, Jiang J-Z, Wan X-F, Hua Y, Wang X, Hou F, et al. Are pangolins the intermediate host of the 2019 novel coronavirus (2019-nCoV)? bioRxiv. 2020. 10.1101/2020.02.18.954628.</mixed-citation></ref><ref id="CR171"><label>171.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>R</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Niu</surname><given-names>P</given-names></name><name><surname>Yang</surname><given-names>B</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name><etal/></person-group><article-title>Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding</article-title><source>Lancet.</source><year>2020</year><volume>395</volume><fpage>565</fpage><lpage>574</lpage><?supplied-pmid 32007145?><pub-id pub-id-type="pmid">32007145</pub-id></element-citation></ref><ref id="CR172"><label>172.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>P</given-names></name><name><surname>Yang</surname><given-names>XL</given-names></name><name><surname>Wang</surname><given-names>XG</given-names></name><name><surname>Hu</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><etal/></person-group><article-title>A pneumonia outbreak associated with a new coronavirus of probable bat origin</article-title><source>Nature.</source><year>2020</year><volume>579</volume><fpage>270</fpage><lpage>273</lpage><?supplied-pmid 32015507?><pub-id pub-id-type="pmid">32015507</pub-id></element-citation></ref><ref id="CR173"><label>173.</label><mixed-citation publication-type="other">U. S. Food and Drug Administration. FDA warns consumers about the dangerous and potentially life-threatening side effects of miracle mineral solution. 2020. Accessed 10 Mar 2020.</mixed-citation></ref><ref id="CR174"><label>174.</label><mixed-citation publication-type="other">The New York Times. Surge of virus misinformation stumps Facebook and Twitter. 2020. Accessed 10 Mar 2020.</mixed-citation></ref><ref id="CR175"><label>175.</label><mixed-citation publication-type="other">BBC News Singapore. Coronavirus: why some countries wear face masks and others don&#x02019;t. 2020. <ext-link ext-link-type="uri" xlink:href="https://www.bbc.com/news/world-52015486">https://www.bbc.com/news/world-52015486</ext-link>. Accessed 26 Jul 2020.</mixed-citation></ref><ref id="CR176"><label>176.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mian</surname><given-names>A</given-names></name><name><surname>Khan</surname><given-names>S</given-names></name></person-group><article-title>Coronavirus: the spread of misinformation</article-title><source>BMC Med</source><year>2020</year><volume>18</volume><fpage>89</fpage><?supplied-pmid 32188445?><pub-id pub-id-type="pmid">32188445</pub-id></element-citation></ref><ref id="CR177"><label>177.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>SY</given-names></name><name><surname>Gao</surname><given-names>RD</given-names></name><name><surname>Chen</surname><given-names>YL</given-names></name></person-group><article-title>Fear can be more harmful than the severe acute respiratory syndrome coronavirus 2 in controlling the corona virus disease 2019 epidemic</article-title><source>World J Clin Cases</source><year>2020</year><volume>8</volume><fpage>652</fpage><lpage>657</lpage><?supplied-pmid 32149049?><pub-id pub-id-type="pmid">32149049</pub-id></element-citation></ref><ref id="CR178"><label>178.</label><mixed-citation publication-type="other">Grace H. Japan may have beaten coronavirus without lockdowns or mass testing. But how? 2020. <ext-link ext-link-type="uri" xlink:href="https://time.com/5842139/japan-beat-coronavirus-testing-lockdowns/">https://time.com/5842139/japan-beat-coronavirus-testing-lockdowns/</ext-link>. Accessed 26 Jul 2020.</mixed-citation></ref><ref id="CR179"><label>179.</label><mixed-citation publication-type="other">Hasan Muhammad B, Mizanur R, Mohammad Tareq H. The COVID-19 pandemic: why are some countries more successful than others? 2020. <ext-link ext-link-type="uri" xlink:href="https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3575251">https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3575251</ext-link>. Accessed 26 Jul 2020.</mixed-citation></ref><ref id="CR180"><label>180.</label><mixed-citation publication-type="other">Alex W. How Spain&#x02019;s coronavirus outbreak got so bad so fast&#x02014;and how Spaniards are trying to cope. 2020. <ext-link ext-link-type="uri" xlink:href="https://www.vox.com/2020/3/20/21183315/coronavirus-spain-outbreak-cases-tests">https://www.vox.com/2020/3/20/21183315/coronavirus-spain-outbreak-cases-tests</ext-link>. Accessed 27 Jul 2020.</mixed-citation></ref><ref id="CR181"><label>181.</label><mixed-citation publication-type="other">Sara B. 5 reasons the coronavirus hit Italy so hard. 2020. <ext-link ext-link-type="uri" xlink:href="https://theconversation.com/5-reasons-the-coronavirus-hit-italy-so-hard-134636">https://theconversation.com/5-reasons-the-coronavirus-hit-italy-so-hard-134636</ext-link>. Accessed 27 Jul 2020.</mixed-citation></ref><ref id="CR182"><label>182.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raghupathi</surname><given-names>V</given-names></name></person-group><article-title>An empirical investigation of chronic diseases: a visualization approach to medicare in the United States</article-title><source>Int J Healthc Manag</source><year>2019</year><volume>12</volume><fpage>327</fpage><lpage>339</lpage></element-citation></ref><ref id="CR183"><label>183.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>BE</given-names></name><name><surname>Ong</surname><given-names>SWX</given-names></name><name><surname>Kalimuddin</surname><given-names>S</given-names></name><name><surname>Low</surname><given-names>JG</given-names></name><name><surname>Tan</surname><given-names>SY</given-names></name><name><surname>Loh</surname><given-names>J</given-names></name><etal/></person-group><article-title>Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore</article-title><source>JAMA.</source><year>2020</year><volume>323</volume><fpage>1488</fpage><lpage>1494</lpage><?supplied-pmid 32125362?><pub-id pub-id-type="pmid">32125362</pub-id></element-citation></ref><ref id="CR184"><label>184.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>F</given-names></name><name><surname>Yu</surname><given-names>T</given-names></name><name><surname>Du</surname><given-names>R</given-names></name><name><surname>Fan</surname><given-names>G</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study</article-title><source>Lancet.</source><year>2020</year><volume>395</volume><fpage>1054</fpage><lpage>1062</lpage><?supplied-pmid 32171076?><pub-id pub-id-type="pmid">32171076</pub-id></element-citation></ref><ref id="CR185"><label>185.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lowen</surname><given-names>AC</given-names></name><name><surname>Mubareka</surname><given-names>S</given-names></name><name><surname>Steel</surname><given-names>J</given-names></name><name><surname>Palese</surname><given-names>P</given-names></name></person-group><article-title>Influenza virus transmission is dependent on relative humidity and temperature</article-title><source>PLoS Pathog</source><year>2007</year><volume>3</volume><fpage>1470</fpage><lpage>1476</lpage><?supplied-pmid 17953482?><pub-id pub-id-type="pmid">17953482</pub-id></element-citation></ref><ref id="CR186"><label>186.</label><mixed-citation publication-type="other">Harvard Health Publishing. Out in the cold. 2010. <ext-link ext-link-type="uri" xlink:href="https://www.health.harvard.edu/staying-healthy/out-in-the-cold">https://www.health.harvard.edu/staying-healthy/out-in-the-cold</ext-link>. Accessed 27 Jul 2020.</mixed-citation></ref><ref id="CR187"><label>187.</label><mixed-citation publication-type="other">Woodward A. High temperatures and muggy weather might make the new coronavirus less contagious, a group of experts says. 2020. <ext-link ext-link-type="uri" xlink:href="https://www.businessinsider.in/science/news/high-temperatures-and-muggy-weather-might-make-the-new-coronavirus-less-contagious-a-group-of-experts-says/articleshow/74697538.cms">https://www.businessinsider.in/science/news/high-temperatures-and-muggy-weather-might-make-the-new-coronavirus-less-contagious-a-group-of-experts-says/articleshow/74697538.cms</ext-link>. Accessed 27 Jul 2020.</mixed-citation></ref><ref id="CR188"><label>188.</label><mixed-citation publication-type="other">Bannister-Tyrrell M, Meyer A, Faverjon C, Cameron A. Preliminary evidence that higher temperatures are associated with lower incidence of COVID-19, for cases reported globally up to 29th February 2020. medRxiv. 2020. 10.1101/2020.03.18.20036731.</mixed-citation></ref><ref id="CR189"><label>189.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>KH</given-names></name><name><surname>Peiris</surname><given-names>JS</given-names></name><name><surname>Lam</surname><given-names>SY</given-names></name><name><surname>Poon</surname><given-names>LL</given-names></name><name><surname>Yuen</surname><given-names>KY</given-names></name><name><surname>Seto</surname><given-names>WH</given-names></name></person-group><article-title>The effects of temperature and relative humidity on the viability of the SARS coronavirus</article-title><source>Adv Virol</source><year>2011</year><volume>2011</volume><fpage>734690</fpage><?supplied-pmid 22312351?><pub-id pub-id-type="pmid">22312351</pub-id></element-citation></ref><ref id="CR190"><label>190.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boldog</surname><given-names>P</given-names></name><name><surname>Tekeli</surname><given-names>T</given-names></name><name><surname>Vizi</surname><given-names>Z</given-names></name><name><surname>D&#x000e9;nes</surname><given-names>A</given-names></name><name><surname>Bartha</surname><given-names>FA</given-names></name><name><surname>R&#x000f6;st</surname><given-names>G</given-names></name></person-group><article-title>Risk assessment of novel coronavirus COVID-19 outbreaks outside China</article-title><source>J Clin Med</source><year>2020</year><volume>9</volume><fpage>571</fpage></element-citation></ref><ref id="CR191"><label>191.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Booth</surname><given-names>TF</given-names></name><name><surname>Kournikakis</surname><given-names>B</given-names></name><name><surname>Bastien</surname><given-names>N</given-names></name><name><surname>Ho</surname><given-names>J</given-names></name><name><surname>Kobasa</surname><given-names>D</given-names></name><name><surname>Stadnyk</surname><given-names>L</given-names></name><etal/></person-group><article-title>Detection of airborne severe acute respiratory syndrome (SARS) coronavirus and environmental contamination in SARS outbreak units</article-title><source>J Infect Dis</source><year>2005</year><volume>191</volume><fpage>1472</fpage><lpage>1477</lpage><?supplied-pmid 15809906?><pub-id pub-id-type="pmid">15809906</pub-id></element-citation></ref><ref id="CR192"><label>192.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donnelly</surname><given-names>CA</given-names></name><name><surname>Ghani</surname><given-names>AC</given-names></name><name><surname>Leung</surname><given-names>GM</given-names></name><name><surname>Hedley</surname><given-names>AJ</given-names></name><name><surname>Fraser</surname><given-names>C</given-names></name><name><surname>Riley</surname><given-names>S</given-names></name><etal/></person-group><article-title>Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong</article-title><source>Lancet.</source><year>2003</year><volume>361</volume><fpage>1761</fpage><lpage>1766</lpage><?supplied-pmid 12781533?><pub-id pub-id-type="pmid">12781533</pub-id></element-citation></ref><ref id="CR193"><label>193.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ijaz</surname><given-names>MK</given-names></name><name><surname>Brunner</surname><given-names>AH</given-names></name><name><surname>Sattar</surname><given-names>SA</given-names></name><name><surname>Nair</surname><given-names>RC</given-names></name><name><surname>Johnson-Lussenburg</surname><given-names>CM</given-names></name></person-group><article-title>Survival characteristics of airborne human coronavirus 229E</article-title><source>J Gen Virol</source><year>1985</year><volume>66</volume><fpage>2743</fpage><lpage>2748</lpage><?supplied-pmid 2999318?><pub-id pub-id-type="pmid">2999318</pub-id></element-citation></ref><ref id="CR194"><label>194.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mangen</surname><given-names>MJ</given-names></name><name><surname>Nielen</surname><given-names>M</given-names></name><name><surname>Burrell</surname><given-names>AM</given-names></name></person-group><article-title>Simulated effect of pig-population density on epidemic size and choice of control strategy for classical swine fever epidemics in The Netherlands</article-title><source>Prev Vet Med</source><year>2002</year><volume>56</volume><fpage>141</fpage><lpage>163</lpage><?supplied-pmid 12450686?><pub-id pub-id-type="pmid">12450686</pub-id></element-citation></ref><ref id="CR195"><label>195.</label><mixed-citation publication-type="other">Camilo R. As the number of elderly people with coronavirus varies between countries. 2020. <ext-link ext-link-type="uri" xlink:href="https://www.nexojornal.com.br/expresso/2020/03/18/Como-o-n%C3%BAmero-de-idosos-comcoronav%C3%ADrus-varia-entre-pa%C3%ADses">https://www.nexojornal.com.br/expresso/2020/03/18/Como-o-n&#x000fa;mero-de-idosos-comcoronav&#x000ed;rus-varia-entre-pa&#x000ed;ses</ext-link>. Accessed 27 Jul 2020.</mixed-citation></ref><ref id="CR196"><label>196.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mas-Coma</surname><given-names>S</given-names></name><name><surname>Jones</surname><given-names>MK</given-names></name><name><surname>Marty</surname><given-names>AM</given-names></name></person-group><article-title>COVID-19 and globalization</article-title><source>One Health</source><year>2020</year><volume>9</volume><fpage>100132</fpage><?supplied-pmid 32368611?><pub-id pub-id-type="pmid">32368611</pub-id></element-citation></ref><ref id="CR197"><label>197.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhai</surname><given-names>Y</given-names></name><name><surname>Du</surname><given-names>X</given-names></name></person-group><article-title>Mental health care for international Chinese students affected by the COVID-19 outbreak</article-title><source>Lancet Psychiatry</source><year>2020</year><volume>7</volume><fpage>e22</fpage><?supplied-pmid 32199511?><pub-id pub-id-type="pmid">32199511</pub-id></element-citation></ref><ref id="CR198"><label>198.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>St John</surname><given-names>RK</given-names></name><name><surname>King</surname><given-names>A</given-names></name><name><surname>de Jong</surname><given-names>D</given-names></name><name><surname>Bodie-Collins</surname><given-names>M</given-names></name><name><surname>Squires</surname><given-names>SG</given-names></name><name><surname>Tam</surname><given-names>TW</given-names></name></person-group><article-title>Border screening for SARS</article-title><source>Emerg Infect Dis</source><year>2005</year><volume>11</volume><fpage>6</fpage><lpage>10</lpage><?supplied-pmid 15705315?><pub-id pub-id-type="pmid">15705315</pub-id></element-citation></ref><ref id="CR199"><label>199.</label><mixed-citation publication-type="other">Jason B. How South Korea reined in the outbreak without shutting everything down. 2020. <ext-link ext-link-type="uri" xlink:href="https://www.npr.org/sections/goatsandsoda/2020/03/26/821688981/how-south-korea-reigned-in-the-outbreak-without-shutting-everything-down">https://www.npr.org/sections/goatsandsoda/2020/03/26/821688981/how-south-korea-reigned-in-the-outbreak-without-shutting-everything-down</ext-link>. Accessed 27 Jul 2020.</mixed-citation></ref><ref id="CR200"><label>200.</label><mixed-citation publication-type="other">Shibani M, Simon D. How the U.S. can defeat coronavirus: Heed Asia&#x02019;s lessons from past epidemics. 2020. <ext-link ext-link-type="uri" xlink:href="https://www.washingtonpost.com/world/asia_pacific/how-the-us-can-defeat-coronavirus-heed-asias-lessons-from-epidemics-past/2020/03/18/9aa7916a-67a5-11ea-b199-3a9799c54512_story.html">https://www.washingtonpost.com/world/asia_pacific/how-the-us-can-defeat-coronavirus-heed-asias-lessons-from-epidemics-past/2020/03/18/9aa7916a-67a5-11ea-b199-3a9799c54512_story.html</ext-link>. Accessed 27 Jul 2020.</mixed-citation></ref><ref id="CR201"><label>201.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Artika</surname><given-names>IM</given-names></name><name><surname>Ma'roef</surname><given-names>CN</given-names></name></person-group><article-title>Laboratory biosafety for handling emerging viruses</article-title><source>Asian Pac J Trop Biomed</source><year>2017</year><volume>7</volume><fpage>483</fpage><lpage>491</lpage><?supplied-pmid 32289025?><pub-id pub-id-type="pmid">32289025</pub-id></element-citation></ref><ref id="CR202"><label>202.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>H</given-names></name><name><surname>Bilal</surname><given-names>M</given-names></name><name><surname>Iqbal</surname><given-names>HMN</given-names></name></person-group><article-title>Improved biosafety and biosecurity measures and/or strategies to tackle laboratory-acquired infections and related risks</article-title><source>Int J Environ Res Public Health</source><year>2018</year><volume>15</volume><fpage>2697</fpage></element-citation></ref></ref-list></back></article>